The QualityStocks Daily Stock List
- Mustang Bio (MBIO)
- Document Security Systems (DSS)
- Cerecor (CERC)
- Lizhi (LIZI)
- Aptose Biosciences (APTO)
- Sayona Mining Limited (DMNXF)
- Pharmagreen Biotech (PHBI)
- Casa Minerals, Inc. (CASXF)
- Pacific Booker Minerals, Inc. (PBMLF)
- VPR Brands LP (VPRB)
- Nkarta, Inc. (NKTX)
- Assembly Biosciences Inc. (ASMB)
Mustang Bio Inc. (NASDAQ: MBIO)
MarketClub Analysis, StockMarketWatch, StreetInsider, QualityStocks, MarketBeat, TraderPower, InvestorPlace and Schaeffer's reported earlier on Mustang Bio Inc. (MBIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Mustang Bio Inc. (NASDAQ: MBIO) (FRA: 2W6) is a clinical stage biopharmaceutical firm that is engaged in the acquisition, development and commercialization of novel gene and cell therapies as possible cures for rare genetic ailments, solid tumors and hematologic cancers.
The firm has its headquarters in Worcester, Massachusetts and was founded in 2015, on March 13th. It operates as part of the biotechnology research services industry and serves patients across the United States. It is also party to license agreements with Minaris Regenerative Medicine GmbH, SIRION Biotech GmbH and Nationwide Children’s Hospital.
The company’s product pipeline is made up of gene therapy programs for X-linked severe combined immunodeficiency, which is a rare genetic immune system condition. The gene therapies for these are MB-207 and MB-107. Patients who are afflicted with the condition don’t live beyond infancy without treatment. The firm also develops a next-generation oncolytic herpes simplex virus treatment termed MB-108; a candidate indicated for pancreatic and prostate cancers called MB-105; a CAR-T formulation for metastatic breast cancer to the brain and GBM (glioblastoma multiforme) termed MB-103; a glioblastoma CAR-T cell program called MB-101; a CAR-T formulation for light chain amyloidosis and multiple myeloma dubbed MB-104; a CAR-T cell program for chronic lymphocytic leukemia and B cell non-hodgkin lymphoma dubbed MB-106 and a CAR-T therapy indicated for myelodysplastic syndrome, acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm dubbed MB-102.
The firm’s MB-106 candidate recently received an acceptance to its Investigational New Drug application from the FDA. This will allow the company to further advance the therapy as a potentially efficacious and safe treatment option for chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma. Meeting previously unmet clinical needs will not only benefit patients who suffer from these ailments but also the firm’s stakeholders.
Mustang Bio Inc. (MBIO), closed Friday’s trading session at $3.27, up 0.615385%, on 1,471,040 volume with 6,509 trades. The average volume for the last 3 months is 2,131,285 and the stock's 52-week low/high is $2.42000007/$5.21999979.
Document Security Systems, Inc. (NYSE American: DSS)
RedChip, Wall Street Resources, StockMarketWatch, StreetInsider, Vantage Wire, MarketBeat, Bull Ventures, StockRockandRoll, PennyStockLocks, Top Secret Stocks, TraderPower, TradersPro, ChartPoppers, QualityStocks, Sling-Shot-Stocks, The Street, OTCtipReporter, Penny Pick Finders, Penny Stock 101, Jason Bond, Investopedia, Infostock, Penny Stock 106, Epic Stock Picks, Buzz Stocks, BUYINS.NET, Hototc, Penny Stock 112, Penny Stock Circle, Pennybuster, PennyStockProphet, Profitable Trader Authority, Wolf of Penny Stocks, Red Chip, Schaeffer's, Stockhouse, StockOnion, StockPicksNYC, Trading News Bulletin, Wealth Insider Alert and PennyStockScholar reported earlier on Document Security Systems, Inc. (DSS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Document Security Systems, Inc. (NYSE American: DSS) is focused on manufacturing, marketing and sale of products that have been designed to protect valuable data from unauthorized re-imaging, counterfeiting, duplication, forgery and scanning.
The firm has its headquarters in Victor, New York and was founded in 1984, on June 16th. It operates through the corporate, direct marketing, technology management, digital, plastics, packaging and printing segments.
The packaging segment is engaged in the production of custom paperboard packaging, which serves clients in the specialty food, toy, photo packaging, beverage and pharmaceutical industries while the plastics segments manufactures surface printed and laminated cards, which include radio frequency identification, biometric, guilloche patterns, micro fine printing, signature panels, holograms, barcodes and magnetic stripes. The direct marketing segment provides services and products directly to the public. On the other hand, the digital segment is involved in researching, developing, marketing and sale of AuthentiGuard while the technology segment involves monetizing patent portfolios through licensing and commercial litigation.
The company also operates HWH and HWHGIG Marketplace, which are direct selling platforms that provide happiness, wealth and health products. They also distribute and market wellness and health products under the Elevate brand while also developing blockchain security technologies for tracing and tracking solutions for cyber securities and supply chain logistics.
The firm recently sold its legacy digital group to Proof Authentication Corporation and is advancing its transformation agenda, which will allow it to focus on new opportunities with higher returns while growing shareholder value. This is bound to bring in more investors and increase share prices.
Document Security Systems, Inc. (DSS), closed Friday’s trading session at $2.72, off by 3.2028%, on 348,550 volume with 2,321 trades. The average volume for the last 3 months is 2,231,736 and the stock's 52-week low/high is $2.45000004/$10.5500001.
Cerecor Inc. (NASDAQ: CERC)
MarketBeat, StockMarketWatch, Promotion Stock Secrets, Streetwise Reports, StreetInsider, BUYINS.NET, The Street and Schaeffer's reported earlier on Cerecor Inc. (CERC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cerecor Inc. (NASDAQ: CERC) (FRA: C6K) is a biopharmaceutical firm that is engaged in developing and commercializing therapies for rare and orphan ailments, as well as psychiatric and neurological disorders.
The firm has its headquarters in Rockville, Maryland and was founded in 2011, on January 31st by Solomon H. Snyder, Barbara S. Slusher, Isaac Blech and Blake M. Paterson. Prior to its name change in March 2011, the firm was known as Ceregen Corporation.
The enterprise is party to a collaboration agreement with the Frontiers in Congenital Disorders of Glycosylation Consortium on a formulation indicated for treating phosphoglucomutase-1 deficiency related congenital disorders of glycosylation, dubbed CERC-801. It operates as part of the pharmaceutical manufacturing industry and conducts its business in the U.S.
The company’s product candidates include a monoclonal antibody currently undergoing phase 2 clinical trials testing its effectiveness in treating pediatric-onset Crohn’s disease and acute respiratory distress syndrome caused by the coronavirus, dubbed CERC-002; an oral mTORC1/2 inhibitor indicated for treating complex lymphatic malformations, termed CERC-006 and an anti-IL-18 antibody indicated for treating systemic juvenile idiopathic arthritis, multiple myeloma and adult onset still disease, dubbed CERC-007. It is also engaged in the development of monosaccharide therapies indicated for treating congenital disorders of glycosylation, dubbed CERC-803, CERC-802 and CERC-801.
The firm’s experimental coronavirus drug formulation recently received Fast Track designation from the U.S. FDA. In addition to this, the firm entered into an agreement with Kyowa Kirin Co. Ltd, which will afford the firm exclusive rights to their CERC-002 candidate for acute respiratory distress syndrome and pediatric-onset inflammatory bowel disease. This move will encourage investments into the firm and is bound to boost share prices.
Cerecor Inc. (CERC), closed Friday’s trading session at $2.63, off by 2.5926%, on 1,026,570 volume with 4,380 trades. The average volume for the last 3 months is 1,822,390 and the stock's 52-week low/high is $1.98000001/$4.50.
Lizhi Inc. (NASDAQ: LIZI)
MarketClub Analysis, StreetInsider, INO Market Report, TradersPro and QualityStocks reported previously on Lizhi Inc. (LIZI), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Lizhi Inc. (NASDAQ: LIZI) is an online audio platform and interactive audio entertainment platform that operates an online-user generated content audio community in the United States and the People’s Republic of China.
The firm has its headquarters in Guangzhou, China and was founded in 2010. It operates as a part of the investment firms’ industry and is party to collaboration agreements with Huawei Mobile Services, BYD DiLink, GAC Motor, GAC AION New Energy Automobile and Xpeng Motors.
The company’s mission is to allow every individual to showcase their talents, be it vocally or in audio-content creation. It is working towards bringing more individuals closer together through voices. Lizhi’s revenue is mainly generated from China and is made up of advertising, podcast and audio entertainment revenue, as well as other revenue.
The enterprise develops the Tiya application, an audio-based social networking product offering which allows its users to connect with other individuals who they share similar interests with, share their daily lives, chat online and entertain themselves. In addition to this, it also develops the LIZHI Podcast, an application which offers curated podcast content and the Lizhi app, which enables users to record and share their voices online. The enterprise is also involved in the sale of virtual gifts to consumers and also offers advertising services.
Lizhi Inc. recently entered into a collaboration with WM Motor to develop WM Motor’s first branded podcast on Lizhi’s podcast application. This will afford the company more opportunities to collaborate with more brands and enterprises, which will not only extend their consumer base but also increase their revenue.
Lizhi Inc. (LIZI), closed Friday’s trading session at $4.55, off by 4.6122%, on 635,279 volume with 3,311 trades. The average volume for the last 3 months is 2,931,055 and the stock's 52-week low/high is $1.95000004/$16.7499008.
Aptose Biosciences Inc. (NASDAQ: APTO)
StockMarketWatch, MarketBeat, Marketbeat.com, Schaeffer's, MarketClub Analysis, StreetInsider, TradersPro, Investing Futures, Daily Trade Alert, Zacks, Trading Concepts, Kiplinger Today, Jason Bond and BUYINS.NET reported beforehand on Aptose Biosciences Inc. (APTO), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Aptose Biosciences Inc. (NASDAQ: APTO) (TSE: APS) (FRA: LTIA) is a clinical stage biotechnology firm that is engaged in the discovery and development of personalized therapies that address various unmet clinical oncological needs in the U.S.
The firm has its headquarters in Toronto, Canada and was founded in 1986. It serves consumers in Canada and has offices in both Toronto and San Diego. Prior to its name change in August 2014, the firm was known as Lorus Therapeutics Inc.
The enterprise develops anticancer drugs that target signal transduction abnormalities and particular epigenetic processes that underlie various life-threatening malignancies. It is party to an agreement with OHM Oncology, which entails developing, manufacturing and commercializing a protein and kinase inhibitor program dubbed APL-581. In addition to this, it is also party to an agreement with Crystal Genomics Inc. for the research, development and commercialization of CG-806 and CG026806, which are undergoing phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, certain non-Hodgkin’s lymphomas, small lymphocytic lymphoma and chronic lymphocytic leukemia.
The company’s clinical programs include a formulation dubbed APTO-253, which is currently in a phase 1a/b clinical trial testing its effectiveness in treating patients with refractory or relapsed blood cancers, and these include high-risk myelodysplastic syndrome and acute myeloid leukemia.
The firm initiated 3 clinical trials which are all underway, one of which focuses on their APTO-253 candidate while the remaining two are focused on their CG-806 candidate. It expects successful results from all studies, given the indicators observed in CG-806’s safety profile and anti-cancer activity. Good results will boost investments into the firm, which will be beneficial to stakeholders.
Aptose Biosciences Inc. (APTO), closed Friday’s trading session at $5.40, up 0.934579%, on 333,138 volume with 2,269 trades. The average volume for the last 3 months is 4,228,385 and the stock's 52-week low/high is $3.3901/$7.90999984.
Sayona Mining Limited (DMNXF)
We reported earlier on Sayona Mining Limited (DMNXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sayona Mining Limited, together with its subsidiaries, engages in the identification, acquisition, evaluation, and exploration of mineral assets in Australia and globally. The Company chiefly explores for lithium and graphite. It formerly went by the name DiamonEx Limited. It changed its corporate name to Sayona Mining Limited in May 2013. Listed on the OTC Markets, Sayona Mining is based in Paddington, Australia.
Sayona Mining’s focus is on sourcing and developing the raw materials required to make lithium-ion batteries. The Company’s primary emphasis is the development of the advanced stage Authier Lithium Project in Quebec. The Authier Project is 45 kilometers northwest of the city of Val d’Or, a major mining service center in Quebec. Authier mineralization is hosted in a spodumene-bearing pegmatite intrusion with more than 18,000 meters of drilling in 139 holes.
The Authier Lithium Project has advanced, near term development potential. It has a Pre-Feasibility Study (PFS) demonstrating technical and economic viability. The Project area comprises 19 mineral claims totaling 653 hectares. It extends 3.4 kilometers in an east-west, and 3.1 kilometers in a north-south direction, respectively. The location of the Mineral claims is over Crown Land. Sayona Mining completed greater than 8,000 meters of drilling during 2016 and 2017.
The Authier Lithium Project is amenable to simple open-cut mining and processing methods. The project is in close proximity to development infrastructure. In July 2016, Sayona acquired 100 percent of the Authier project for CAD$4 million. In addition, the Company controls a portfolio of lithium and graphite exploration projects in Western Australia.
Concerning Western Australia, Sayona Mining has 17 tenements in the Pilbara Region, covering a total area of 1918km2. Of these, nine were acquired by way of a deal with Great Sandy, with the Mallina Project – E47/2983, being the flagship project.
The East Kimberley Graphite Project is Sayona’s strategic entry into the graphite market. In 2015, the Company announced a strategic entry into the large flake graphite market through securing a large ground position in the East Kimberley area of Western Australia. The Kimberley region is a proven province for high purity, large flake graphite.
The East Kimberley project is 240 kilometers south of Wyndham Port and 220 kilometers south-south-west of the regional center, Kununurra. The Project includes one granted tenement and three separate tenement applications. The Project covers 278 km2. It comprises two areas, Keller and Corkwood. Sayona Mining has 100 percent of the graphite interests across four tenements in the East Kimberley, following the completion of two option-to-purchase agreements.
Sayona Mining previously reported the start of a testing program to produce lithium carbonate and lithium hydroxide from the Authier pilot plant lithium concentrate. The Company recently completed a pilot plant program that processed five tons of Authier drill core into greater than 400 kilograms of spodumene concentrate.
This program demonstrated that a 6 percent Li2O concentrate could be produced at a metallurgical recovery of 79 percent. SGS Canada, Inc. will perform the downstream testing program.
Sayona Mining Limited (DMNXF), closed Friday’s trading session at $0.033, up 26.9231%, on 14,708,609 volume with 238 trades. The average volume for the last 3 months is 4,506,602 and the stock's 52-week low/high is $0.004/$0.054299999.
Pharmagreen Biotech Inc. (OTC: PHBI)
Small Cap Firm, QualityStocks, StockWireNews, StockHideout, Fierce Analyst, Leading Penny Stocks and InvestorPlace reported previously on Pharmagreen Biotech Inc. (PHBI), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Pharmagreen Biotech Inc. (OTC: PHBI) is a biotech solutions firm that specializes in services and products in the marijuana industry. The firm, which has been incorporated in Nevada, also has a hand in the airport business, which includes airport terminal services and flying fields.
The firm is focused on producing starter plantlets for medical marijuana and CBD hemp industries. Additionally, Pharmagreen Biotech, which serves consumers in America, provides technology for tissue culture science such as DNA identification and testing services, isolates and formulations from hemp plants and CBD oils.
The company, which is based in Deroche, British Columbia; Canada, also provides various services, including nurseries and cold storage for plantlets. Founded on Jan.1, 2007, the firm’s future brand of products will center on the marketing and manufacturing of marijuana products for both recreational and medical markets in Canada, with plans to expand to the international markets.
Pharmagreen Biotech Inc., which is one of the biggest producers of hemp plantlets globally, owns a subsidiary known as WFS Pharmagreen Inc. As of early 2021, the biotech company is in the application process for the Access to Cannabis for Medical Purposes Regulations with Health Canada and plans to venture further into the CBD and hemp industry.
This will not only provide better opportunities for the firm but also build infrastructure in America which will generate revenues while providing a competitive advantage that starts with farmers, to non-THC cannabinoids and CBD extraction, to product development, through sales. This will bring good returns to both the firm and its shareholders.
Pharmagreen Biotech Inc. (PHBI), closed Friday’s trading session at $0.053, up 151.1848%, on 86,424,119 volume with 3,939 trades. The average volume for the last 3 months is 3,177,068 and the stock's 52-week low/high is $0.006399999/$0.824999988.
Casa Minerals, Inc. (CASXF)
We reported previously on Casa Minerals, Inc. (CASXF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Casa Minerals, Inc. engages in the acquisition, exploration and development of mineral properties situated in Canada. It owns a 100 percent interest in the polymetallic Pitman and Keaper properties and has an option to acquire a 75 percent interest in the Arsenault VMS Property. The Company primarily explores for gold, copper, silver, as well as molybdenum. Casa Minerals has its head office in Vancouver, British Colombia. The Company lists on the OTC Markets.
The Pitman Property consists of seven contiguous mineral tenures encompassing 5,506 hectares. It is positioned 20 kilometers north of Terrace, British Columbia. The Pitman Property includes a number of historic prospects. These include the Pitman copper-molybdenum ± silver prospect, and the Gold Dome and Paddy Mac gold-base metal prospects.
The polymetallic Keaper Property is 20 kilometers northeast of Terrace, British Columbia. This Property consists of 3,790 hectares. It is undergoing exploration for copper, silver and gold. Planning and permitting for exploration of Casa Minerals’ properties is in progress.
The Company’s Arsenault VMS Property consists of three mineral tenures encompassing roughly 2,751 hectares positioned in the Atlin Mining Division, British Columbia. In recent years, Casa has conducted a number of exploration programs on the Arsenault Property. It has developed an attractive volcanogenic massive sulphide (VMS) exploration target. More work is planned with the goal of proceeding to a drilling program to test a number of areas identified by geological mapping, prospecting, and geophysical and geochemical surveys.
Recently, Casa Minerals announced the appointment of Mr. Jim (James) D. Clucas to its Board of Directors. Mr. Jim Clucas brings considerable experience and management skills gained from executive roles in senior and junior levels of mineral exploration, mining and development to Casa Minerals. Mr. Clucas is a Co-Founder of INV Metals presently trading on the TSX Venture Exchange. He was previously the Executive Chairman and President of Search Minerals, Inc., also a TSX Company.
Casa Minerals, Inc. (CASXF), closed Friday’s trading session at $0.198601, up 85.956%, on 14,991 volume with 8 trades. The average volume for the last 3 months is 302,000 and the stock's 52-week low/high is $0.037149999/$0.218199998.
Pacific Booker Minerals, Inc. (PBMLF)
QualityStocks and MarketBeat reported previously on Pacific Booker Minerals, Inc. (PBMLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Pacific Booker Minerals, Inc. (PBMLF) owns the Morrison property in Central British Columbia, 35 km north of the Village of Granisle. The Company is in the advanced stage of development of the Morrison porphyry copper/gold/molybdenum deposit. PBM has completed a Feasibility Study (FS) and 43-101 compliant Technical Report. It is proposing an open-pit mining and milling operation for the production of copper/gold/molybdenum concentrate from the Morrison deposit. The Company purchased the Morrison property in April of 2004. PBM is based in Vancouver, British Columbia.
The total mineable reserve (according to the FS), classified as proven and probable, at Net Smelter Return (NSR) cut-off-value of $CDN5.60/t, is 224.25Mt with an average grade of 0.330% Copper, 0.163g/t Gold and 0.004% Molybdenum. FS highlights also include recovered metal of 1.37 billion lbs Copper, 658,090 oz Gold, and 10.047 million lbs Molybdenum. The Mine life is 21 years.
PBM previously announced that the Chief Gold Commissioner issued a mining lease in the area known as the Morrison mine project and consisting of mineral claims 625123, 625143, and 625183, covering about 1,090 ha, for an initial term of one year and not the maximum 30-year term requested by PBM in its August 28, 2009 application. The three mineral claims are situated along the shore of Morrison Lake, roughly 65 kilometers northeast of Smithers, British Columbia.
The Morrison deposit has the advantage of existing regional infrastructure to service the region. This includes a deep-sea shipping terminal at the port of Stewart, B.C., a road network, nearby hydro-electric power (20 km from the project site), two existing nearby forestry camps for preproduction use, and a full service town (the Village of Granisle) within daily commuting distance from the project site.
The Feasibility Study for the Morrison property was completed by Wardrop Engineering Ltd., a Tetra Tech Company, with technical support of a team of other consultants. The study describes the scope, design features and financial viability of a conventional open pit mine with a 30,000 tonnes per day mill.
Recently the Company's Mining Lease #1069796 which had been previously cancelled received approval for renewal. In the Reasons for Decision document, the Chief Gold Commissioner states, "In exercising my discretion to reinstate mining lease 1069796, the factors I consider to be of particular significance are the long standing exploration history and development, the significant investment of PBM to date, the extraordinary prejudice to PBM compared to the relatively small impacts to the intervening claim holders, and the inadvertent nature of PBM's error."
Pacific Booker Minerals, Inc. (PBMLF), closed Friday’s trading session at $3.10, up 50.4854%, on 3,200 volume with 20 trades. The average volume for the last 3 months is 2,579 and the stock's 52-week low/high is $1.03999996/$3.0999999.
VPR Brands LP (VPRB)
QualityStocks, NetworkNewsWire, StocksToBuyNow, SmallCapRelations, CannabisNewsWire, Tip.us, SeriousTraders, Wolf of Penny Stocks, PoliticsAndMyPortfolio, Epic Stock Picks, StockRunway, The Observer, Wall Street Mover, PennyPickz, PennyDoctor, Wallstreet Profiler, KingPennyStocks and SmallCapGrowth reported previously on VPR Brands LP (VPRB), and today we report on the Company, here at the QualityStocks Daily Newsletter.
VPR Brands (OTC: VPRB), a market-leading supplier and patent holder for electronic cigarettes or vaporizers for nicotine, cannabis and cannabidiol (“CBD”) and other related accessories, has released its first quarter 2021 financial results. The report was highlighted by an increase in quarterly revenues of approximately 209% over the same quarter last year, totaling $1.25 million, along with a reduction in net loss from $421,590 in 2020 to $101,651 in 2021.
The report also noted that VPR Brands was able to strengthen its gross operating margins to 43% in Q1 2021 compared with 35% in Q1 2020. The report noted that the company made significant progress in regaining revenues lost because of COVID-19; the company pointed to increases in its direct-to-customer business and the addition of Dissim Lighters to its portfolio as key components to its ability to trend upward. “We are back in business,” said VPR Brands CEO Kevin Frija in the press release. “After a difficult year in 2020 due to circumstances beyond our control, we are grateful to be able to come back strong and continue where we left off in 2019 and we look forward to the rest of 2021 and beyond.”
To view the full press release, visit https://nnw.fm/CmVXm
VPR Brands is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products including technology for medical marijuana vaporizers and electronic cigarette products and components as well as lighters. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes), which are devices that deliver nicotine and/or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information about the company, visit www.VPRBrands.com.
VPR Brands LP (VPRB), closed Friday’s trading session at $0.0625, up 35.722%, on 537,365 volume with 45 trades. The average volume for the last 3 months is 426,857 and the stock's 52-week low/high is $0.006099999/$0.25.
Nkarta, Inc. (NASDAQ: NKTX)
StreetInsider reported previously on Nkarta, Inc. (NKTX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Nkarta (NASDAQ: NKTX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Nkarta is presenting preclinical data at ASCO for NKX101 in solid tumor models (abstract here). NKX101 appears to be active both in cell lines and in a xenograft mouse model, specifically in the latter when being delivered regionally and not systemically. Despite the early nature of these studies, it is worth noting that little data was previously available for this setting, so today’s released abstract seems to keep building the potential of NKX101 in solid tumors, which could reach the clinic in 2023.”
To request access to the full report, visit http://nnw.fm/SaZ9d
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer patients. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, which are engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta, Inc. (NKTX), closed Friday’s trading session at $26.50, off by 6.0284%, on 383,479 volume with 2,257 trades. The average volume for the last 3 months is 246,801 and the stock's 52-week low/high is $22.4601993/$76.5026016.
Assembly Biosciences Inc. (NASDAQ: ASMB)
MarketBeat, Trades Of The Day, TraderPower, StreetInsider, MarketClub Analysis, BUYINS.NET, Zacks, TradersPro, TopPennyStockMovers, The Best Newsletters, StockMarketWatch, Marketbeat.com, Market FN and Daily Trade Alert reported previously on Assembly Biosciences Inc. (ASMB), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Assembly Biosciences (NASDAQ: ASMB) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We are updating our model post the 1Q21 print (no major changes, PT still $13). The stock hit a new all-time low last night, closing at $3.90, and is now trading ~$1.50 below cash value, with enough cash ‘into 2023.’ . . . Here’s the thing: when I look at the HBV landscape, I find it difficult to exclude core inhibitors from what may be the eventual cocktail for finite treatment. Mechanistically, they effectively work upstream of nucs and they knock down HBV RNA better than siRNAs. And when I look at core inhibitors, ASMB has best-in-class potential given it is building its pipeline using novel chemotypes (i.e. should be safer than derivative chemotypes from everything we have seen), and that is even intra-pipeline among its core inhibitors.”
To request access to the full report, visit http://nnw.fm/l4Rxd
Assembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assembly Bio’s approach aims to break the complex viral replication cycle of HBV to free patients from a lifetime of therapy. Assembly Bio’s strategy toward cure includes a leading portfolio of more potent, next-generation core inhibitors, proof-of-concept combination studies and a research program focused on the discovery of novel HBV targets. For more information, visit the company’s website at www.AssemblyBio.com.
Assembly Biosciences Inc. (ASMB), closed Friday’s trading session at $4.05, up 0.496278%, on 804,140 volume with 3,984 trades. The average volume for the last 3 months is 1,063,279 and the stock's 52-week low/high is $3.80999994/$27.8400001.
Featured Whitepapers
A Case for Small & Micro-Cap Investing
Avenel Financial Group’s (AFG) financial research analysts and interns researched the top performing Microcap investors, studied their investments, and analyzed quantitative and qualitative metrics along with the historical performance of this asset class.
Featured Whitepaper
XPEL Case Study
Did You Miss Your Opportunity on This 100-Bagger?
As a continuation of our study of Super Compounders we will evaluate one of the more prominent 100-Baggers of the past decade. XPEL technologies is a company that has rose to dominate the niche space of protective films for car paint and has rapidly grown through intelligent capital allocation and acquisitions. Paul Andreola of Smallcap Discoveries first brought this to MicroCapClub in 2013. Attached is an in-depth analysis of its meteoric rise, which we hope will help you to spot the next 100-Bagger.
Featured Whitepaper
Quality Shareholders
Lawrence A. Cunningham discussed the makeup of the modern shareholder group in his recent book “Quality Shareholders.” In this paper we briefly discuss the primary takeaways and applications of the concepts in this book and the advantages inherent in the active cultivation of a quality, engaged shareholder cohort. The insights in Cunningham’s book are impactful and may illuminate new strategies for evaluating a firms management.
“Managers get the shareholders they deserve.” – Lawrence Cunningham
The QualityStocks Company Corner
- SRAX Inc. (NASDAQ: SRAX)
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)
- Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF)
- Energy Fuels Inc. (TSX: EFR) (NYSE American: UUUU)
- Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF)
- Aterian, Inc. (NASDAQ: ATER)
- XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTCQB: XPHYF)
- Brain Scientific Inc. (OTCQB: BRSF)
- HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF)
- Sharing Services Global Corporation (SHRG)
- Healthy Extracts Inc. (HYEX)
SRAX Inc. (NASDAQ: SRAX)
The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).
- SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced the launch of the Sequire Investor Community, an information hub and interactive environment designed to cater to the platform’s growing network of investors (https://ibn.fm/3aDBb)
- SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, is partnering with InvestorBrandNetwork (“IBN”) for the upcoming LD Micro Invitational XI event. The all-digital conference, scheduled for June 8–10, 2021, will hosted by LD Micro, which was recently acquired by SRAX. IBN, which has worked with LD Micro for almost a decade, is an innovative corporate communications agency and diversified content distributor. LD Micro has built a reputation for hosting some of the most influential conferences across the small-cap space, and this year’s LD Micro Invitational, which is the 11th annual gathering, will provide attendees with invaluable information about and access to an estimated 180 companies with exciting potential. The conference agenda includes 25-minute presentations from each of those companies, as well as an inspiring list of influential thought leaders and keynote speakers. IBN’s InvestorWire will provide comprehensive coverage of the event, while IBN will provide social media coverage via more than 50 investor-oriented brands that collectively have more than 2 million likes and followers across a variety of platforms. “We look forward to collaborating once again with Chris Lahiji and his amazing team as we work collectively to raise the visibility of some of North America’s most exciting micro and small-cap companies,” said IBN director of communications Jonathan Keim in the press release. “This well-experienced organization is renowned throughout the space for its innovative events, and we are very excited to continue working alongside the organizers.” To register for the event, visit https://ibn.fm/WBnNL. To view the full press release, visit https://ibn.fm/AoX8U.
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
SRAX Verticals
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
International Expansion
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Leadership
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Friday’s trading session at $4.57, up 1.5556%, on 788,906 volume with 2,790 trades. The average volume for the last 3 months is 792,266 and the stock's 52-week low/high is $1.62999999/$7.19500017.
Recent News
- SRAX Inc. (NASDAQ: SRAX) Announces Launch of Sequire Investment Community
- InvestorNewsBreaks - SRAX (NASDAQ: SRAX) to Collaborate with IBN for LD Micro Invitational XI Conference
- InvestorNewsBreaks - SRAX (NASDAQ: SRAX) Releases Q1 Revenue Growth, Increases Full-Year Guidance
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)
The QualityStocks Daily Newsletter would like to spotlight Red White & Bloom Brands Inc. (OTCQX: RWBYF).
Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) today announced the results of the special meeting of the holders of common shares and the Series 2 convertible preferred shares and a class meeting of the holders of the Series 2 convertible preferred shares. At the meeting, shareholders representing 99.62% of the votes cast attached to the common shares and the Series 2 preferred convertible shares, as well as 98.44% of the votes cast attached to the series 2 convertible preferred shares, voted to approve a special resolution authorizing the company to alter its articles to, in effect, change the conversion date of the Series 2 convertible preferred shares. The change is such that each Series 2 shareholder shall be entitled to convert any whole number of Series 2 convertible preferred shares into validly issued, fully paid and non-assessable common shares on any business day after the eighteenth month anniversary (Oct. 24, 2021) of the date upon which the Series 2 convertible preferred shares were issued by the company. To view the full press release, visit https://ibn.fm/2kNSA
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) is a torchbearer blazing a new frontier in American cannabis by adhering to the highest ethical, manufacturing, educational, branding and employment standards available in the industry.
Red White & Bloom is a super state operator, leveraging a sizable footprint to dominate the areas in which it operates. CEO Brad Rogers and other management members have seen the struggles of multi-state operators who have spread themselves too thin, which is why Red White & Bloom is intent on dominating each state it enters before expanding further.
Although targeting individual states in the United States, the company is headquartered in Toronto, Canada. Red White & Bloom was established after privately held MichiCann Medical Inc. merged with publicly traded Tidal Royalty in 2019.
Brands
Red White & Bloom has entered strategic brand acquisitions and partnerships aimed at helping the company expand its presence and position as one of the largest players in the United States cannabis market. Red White & Bloom is always diligently searching for brands to acquire that will provide additional value to the company and expand its national footprint.
The company’s current brand portfolio includes:
- Platinum Premium Cannabis Products (PV): Platinum uses innovative thinking, honesty and responsibility to remain at the forefront of the cannabis industry. PV holds itself and its partners to the highest standards, providing clean and safe CBD and THC products. In the company’s press release dated January 13, 2021, it reported system-wide sales of Platinum-branded products exceeding $2.8 million for the first week of January alone.
- High Times®: In June 2020, the company acquired the licensing rights and branding of High Times dispensaries and High Times cannabis-based CBD and THC products in Michigan, Illinois and Florida. The company also acquired branding of High Times hemp derived CBD products nationally in the United States carrying the Culture® brand.
- Mid-American Growers: Mid-American began as a family operation in 1971 in Granville, Illinois. The original 8-acre greenhouse has expanded to a 3.6-million-square-foot, state-of-the-art technology and science facility under glass. Mid-American’s product offerings include its CBD Icy Relief Salve, CBD Icy Relief Roll-on and CBD Gummies.
Retail Focus
Red White & Bloom is working to establish a significant retail presence across multiple jurisdictions. In Michigan, the company is invested in and has the rights to acquire (subject to regulatory approvals) a licensed operator that controls the assets of 18 dispensary locations throughout the state. Red White & Bloom is also pursuing opportunities in Florida aimed at making its proposed retail footprint compelling and attractive to the majority of cannabis consumers within each state.
Cultivation
Red White & Bloom is focused on standardization and quality, with everything guided by a relentless commitment to the highest standards. The company acquired a 3.6-million-square-foot standardized facility dedicated to helping it achieve premium value for the products it intends to cultivate.
As it continues to expand, the company remains committed to the practices that have guided its success in the past, including:
- A top-down approach to cultivation developed under the guidance of PhDs with expertise in growing principles, SOPs and, most importantly, the science behind it all.
- Commitment to exceeding the requirement of the states in which it operates. The company cut its teeth under the world’s first national cannabis purity regime – a regime that most new markets use as a benchmark – so quality is in its DNA.
- Science-driven production methods supported by automated, perpetual, standardized operations that enable craft cannabis-like quality at an industrial scale.
Footprint
Assuming completion of the currently proposed investments and acquisitions, Red White & Bloom will be among the cannabis market’s largest companies, joining the ranks of a select few multi-state operators dominating the industry. Red White & Bloom currently has assets (closed and in closing stages) in Michigan, Illinois, Florida, California, Oklahoma and Massachusetts.
The company’s strategic acquisition and super state operator model, combined with its commitment to top-quality product and service, position it to become a leading player in the North American cannabis market.
When evaluated beside competitors in the cannabis space, Red White & Bloom boasts an extremely attractive valuation. While large cap cannabis firms serving North American markets averaged enterprise-value-to-EBITDA multiples of 14.9x as of December 2020, Red White & Bloom’s enterprise multiple was just 3.4x, as noted in the company’s latest investor deck.
In 2020, the cannabis market worldwide was valued at $24.6 billion. This amount is expected to expand at a CAGR of 14.3% from 2021 to 2028, resulting in a market size of $84 billion in 2028 (https://nnw.fm/f09ZL). Of the 2020 valuation, the largest revenue share (91.1%) was attributed to North American consumers (https://nnw.fm/vObW6).
Management Team
Brad Rogers is the CEO and Executive Chair of Red White & Bloom. He is a visionary for the future of cannabis and CBD products in the United States market, with a proven track record of building successful and profitable businesses in the rapidly expanding and new economic sector. Mr. Rogers was a part of the team that built one of the first commercially scaled production facilities in the world for medicinal cannabis. He also served as President for one of the leading licensed producers in Canada. Both of his ventures were successful, with a combined market cap of $2 billion.
Michael Marchese is the company’s Co-Founder and Marketing Advisor. He has played a crucial role in its development and organization, overseeing capital raises, acquisition strategy and brand identity. Mr. Marchese has a strong reputation and presence in the cannabis industry. He also co-founded and directed the branding of Aleafia Health Inc., which he continues to counsel. Through his branded company, Marchese Design, he has served as a highly trusted counselor to top-level execs, including C-Suite level employees, offering insights into the process of creating, building and maintaining brand identities.
Theo van der Linde is the CFO and Director of Red White & Bloom. He is a Chartered Accountant with 20 years of experience in finance, administration and public accounting. The experience he has acquired spans multiple industries, including mining, oil & gas, financial services, retail and manufacturing. For the last nine years, he has primarily focused his career on the mining industry, working with junior exploration and producing mining companies at various stages of growth in several jurisdictions. Mr. van der Linde is also the current President of Executive Management Solutions Ltd.
Red White & Bloom Brands Inc. (RWBYF), closed Friday’s trading session at $0.91, up 2.0752%, on 347,816 volume with 257 trades. The average volume for the last 3 months is 495,722 and the stock's 52-week low/high is $0.330000013/$1.64999997.
Recent News
- InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Shareholder Approval of Deferred Conversion Date of Preferred Shares
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Is Mobilizing 30 Turn-Key Grow Pods to Provide Florida With Premium Cannabis
- InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Releases Update on Management Cease Trade Order
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)
The QualityStocks Daily Newsletter would like to spotlight Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF).
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of a broadcast titled, “Wall Street Unicorns in Process of Changing the Healthcare Landscape.” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast. To view the full editorial, please visit: https://nnw.fm/QOAcO
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) is a pharmaceutical company focused on developing clinical-stage compounds for diseases with high unmet medical needs through accelerated regulatory pathways.
The company was founded in 2019 and is headquartered in San Diego, California.
Innovative Drug Pipeline
Tryp’s current focus is on advancing its two drug development platforms: its Psilocybin-for-Neuropsychiatric Disorders (PFN™) program targeting fibromyalgia, eating disorders and chronic pain conditions; and razoxane for soft tissue sarcomas. The company intends to explore opportunities to monetize these platforms after generating Phase 2b clinical data.
The company’s development plans cover three strategic initiatives:
- Develop: Tryp intends to utilize the FDA’s 505(b)(2) regulatory pathway with available third-party preclinical data to shorten the timelines and lower the cost of its development programs.
- Protect: Tryp plans to utilize regulatory exclusivity, patents, trade secrets and proprietary know-how to protect the commercial lifespan of its drug candidates.
- Monetize: Tryp intends to seek out licensing, acquisition and co-development opportunities for drug candidates following their Phase 2 stages of development.
PFN™ Program
Through its PFN™ program, the company is focused on developing psilocybin-based drug therapies for certain neuropsychiatric disorders that have distinct advantages over other drugs currently on the market or in development. These advantages include:
- Increased efficacy
- Natural blood-brain barrier penetration
- Enhanced safety and toxicity profiles
- Reduced risk of abuse
- Reduced risk of addiction
Tryp’s PFN™ program features its lead drug candidate, TRP-8802. The company’s initial indication for TRP-8802 is fibromyalgia.
Fibromyalgia is believed to be a neurosensory disorder characterized in part by abnormalities in pain processing by the central nervous system. The three drugs with FDA approval for the treatment of fibromyalgia are Pregabalin (Lyrica®), Duloxetine (Cymbalta®) and Milnacipran (Savella®), which are only effective for a portion of patients suffering from the condition.
Tryp plans to seek FDA approval to proceed directly to Phase 2 clinical trials evaluating TRP-8802 as a treatment for fibromyalgia based on existing preclinical and clinical data for the active pharmaceutical ingredients in TRP-8802.
Tryp’s pipeline of indications for TRP-8802 also includes eating disorders and certain forms of chronic pain. The company expects to initiate Phase 2a clinical trials in these areas in 2021.
Tryp recently partnered with Albany Molecular Research Inc. (“AMRI”) for the manufacture of the company’s synthetic psilocybin using proprietary methods. AMRI has initiated the process of manufacturing a 200g non-GMP demonstration batch of psilocybin and will produce a batch of GMP psilocybin in mid-2021. As the holder of the Drug Master File, Tryp expects to be the only U.S.-based manufacturer of synthetic psilocybin in the industry.
Razoxane
Tryp’s second drug candidate, TRP-1001 (razoxane), is being developed as a treatment for soft tissue sarcomas and has been evaluated in multiple Phase 2 clinical trials conducted by clinicians unaffiliated with Tryp. The company believes that existing clinical data regarding razoxane will likely allow TRP-1001 to be studied in a Phase 2 trial without the need for extensive preclinical or Phase 1 trials.
Sarcomas are rare tumors that are derived from connective tissues in the body and comprise 7% of all cancers in children. In 2018, an estimated 13,000 new cases of soft tissue sarcoma were diagnosed, with the tumors resulting in over 5,000 deaths during that year in the United States alone (https://ibn.fm/nWOGq).
Market Outlook
With its drug development programs targeting multiple indications, Tryp is well positioned to capitalize on growth opportunities spanning a range of therapeutic markets. The global oncology drugs market, in particular, represents a sizable opportunity.
In 2018, oncology indications accounted for 25% of all drug sales, representing approximately $151 billion in market revenues. By 2024, spending on oncology-targeted therapeutics is expected to top $200 billion and account for roughly 30% of total drug sales, according to a study by Cowen Equity Research (https://ibn.fm/9iZhM).
Valued at $764 million in 2020, the global fibromyalgia treatment market presents unique opportunities for development due to the limited number of approved therapies. With treatment trending upward, the market is expected to grow at a CAGR of 9.2% and reach $1.4 billion in value by 2027 (https://ibn.fm/G66e7).
Management Team
Greg McKee is the Chairman and CEO of Tryp Therapeutics. He has more than 20 years of life sciences management and venture investment experience that he brings to the company. Before taking his role at Tryp, he was the founder of Torrent Ventures, an early-stage digital health and medical technology venture fund. Mr. McKee also served as the CEO of CONNECT, the largest Southern California start-up accelerator. Before this, he was the chairman, president and CEO of then publicly traded Nventa Biopharmaceuticals, which successfully merged with Akela Pharma. Mr. McKee earned a B.A. in Economics from the University of Washington, an M.A. in International Studies from The Joseph H. Lauder Institute, and an MBA from the Wharton School at the University of Pennsylvania. He has been a member of the Young President’s Organization (YPO) since 2006.
James Gilligan, Ph.D., is the company’s President and Chief Science Officer. He has over 35 years of experience in the life sciences industry, including research and development, clinical development, international regulatory affairs and manufacturing. Before joining Tryp, Dr. Gilligan was the Co-Founder and Managing Partner of The Bracken Group, a life sciences consulting firm. He was also the Co-Founder of Unigene Laboratories, which develops technology for the recombinant manufacture of peptide hormones. Dr. Gilligan received his Ph.D. in Pharmacology from the University of Connecticut and a MSIB from Seton Hall University. He continued his post-graduate education at the Roche Institute of Molecular Biology.
Tom D’Orazio is the Chief Operating Officer of Tryp Therapeutics. He has extensive experience in leading the development and commercialization of vaccines, drugs, radiopharmaceuticals and biologics. His prior leadership experience has been in commercial planning, marketing, partnership and business development roles. He was formerly the CEO of ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), where he led the transition from a private company to a public one. He co-founded and served as CEO of Superna Life Sciences, a specialty-pharma company focusing on niche drugs for cancer patients in Canada. Mr. D’Orazio has an MBA from Vanderbilt University with a primary focus in both finance and marketing and a B.Sc. in chemistry from Loyola University of Chicago.
Luke Hayes is the company’s Chief Financial Officer. He has played an active role in the life science industry for over 20 years with technology transfer, venture capital and finance experience. His career started with business development for Dow Chemical (NYSE: DOW), with responsibility for pharmaceutical customers such as Eli Lilly and AbbVie. Mr. Hayes has spent more than a decade doing venture capital investing while supporting companies as a director and advisor. He earned a B.S. in Chemical Engineering from Brigham Young University and an MBA from the UCLA Anderson School of Management.
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), closed Friday’s trading session at $0.608, up 0.346592%, on 133,611 volume with 107 trades. The average volume for the last 3 months is 73,726 and the stock's 52-week low/high is $0.449999988/$1.03999996.
Recent News
- Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Brings Best-in-Class Team to Psychedelics Development
- Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- BioMedNewsBreaks - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leverages Key Initiatives to Advance Drug Candidates
GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF)
The QualityStocks Daily Newsletter would like to spotlight GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF).
GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) was featured today in a publication from MiningNewsWire, examining how many mining companies across the globe are adopting the use of autonomous haulage systems (“AHS”), which not only improve the safety of mining operations but also improve maintenance and efficiency. This technology decreases the risk of injuries at mining sites by automating haulage operations and reducing the number of individuals needed around mining equipment. Additionally, the systems help avoid shift changes or breaks, which are linked to the use of manned machines. This also allows miners to decrease fuel emissions and consumption.
GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (formerly Altum Resources Corp.), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, recently announced its entry into agreements to acquire seven advanced gold projects in the Maricunga Gold Belt of Chile that hosts over 100 million ounces of gold within the last 10 years.
Chilean Gold Properties Being Acquired
On April 17, 2020, GoldHaven Resources entered into an agreement to purchase a 100% interest in two gold projects located in the Maricunga Gold Belt of Northern Chile. The first property, Rio Loa, is located 25 kilometers south of Gold Fields Ltd.’s Salares Norte, where, this year, a five-million-ounce discovery was made. The second property, Coya, is located only 10 kilometers east of the Kinross La Coipa open pit mine, which has produced over 7.5 million ounces of gold to date.
Rio Loa Project
Initial geophysical studies of the Rio Loa site have exposed highly anomalous ardennite and lead values, a key characteristic of gold mineralization within silicified resistive bodies. The studies have also produced initial findings which are similar to those seen at contiguous mines, such as Salares Norte (operated by Gold Fields), which has over five million ounces in estimated gold deposits.
The potential economics for the site look particularly promising when taking the unit costs at the neighboring Salares Norte mine into account. Gold Fields has estimated that its production AISC (all-in sustainable costs) will approximate $552 per ounce and have forecast a 2.3-year payback period for its initial investment, assuming a $1,300 per ounce gold price.
Coya Project
The Coya site is located within close proximity to one of the richest and largest epithermal gold and silver districts in Chile and is in close proximity to active mining sites, specifically the La Coipa mine owned by Kinross. A study carried out in 2017-2018 on the Coya site of 796 rock chip samples found favorable gold and silver values, in some cases ranking as high as 764 grams/tonne of gold and 719 grams/tonne of silver – values which are near certain indicators of potential gold and silver deposits. The La Coipa mine (Kinross) has produced over 6.9 million ounces of gold to date.
On August 11, 2020, GoldHaven Resources acquired five potential gold projects in the Maricunga Gold Belt of Northern Chile. The Maricunga hosts discoveries within the last 10 years of over 100 million ounces of gold and over 450 million ounces of silver. These newly acquired properties are in close proximity to seven other mines, which possess an estimated aggregate of 81 million ounces of gold in total reserves.
GoldHaven’s five new projects cover a total area of approximately 22,600 hectares, or 226 square kilometers, located in the northern portion of the Maricunga Belt in proximity to the 5 million-ounce gold equivalent Salares Norte project owned by Gold Fields. Gold Fields announced in April 2020 its intention to proceed with the development of Salares Norte at a cost of $860 million, with a $138 million expenditure budgeted for 2020.
The Maricunga Belt extends approximately 150 kilometers north-south and 30 kilometers east-west, straddling the border between Chile and Argentina. This region hosts known mineral resources of more than 100 million ounces of gold, 450 million ounces of silver and 1.3 billion pounds of copper.
The Maricunga project’s opportunity came about as a result of a $150 million initiative launched by the Chilean Economic Development Agency (“CORFO”), with the objective of encouraging exploration and mining prosperity in Chile and strengthening Chile’s position as a world leader in the sector.
As part of CORFO’s program, a total of $15.3 million was given to private equity fund IMT Exploration to evaluate 403 projects, beginning in 2011. This led to a generative program carried out from 2016 to 2019, resulting in 126 potential epithermal targets from which 57 field evaluations were made. Due diligence work followed on 19 of these. Work programs were then conducted, including geological mapping, rock and soil sampling and TerraSpec (PIMA) analyses on geochemical grids for alteration mapping, and, as a result, the five high-priority Maricunga projects were identified. No drilling has been carried out on any of the Maricunga projects.
Securing Financing for Upcoming Operations
In conjunction with its announcement regarding its acquisition of five Chilean mining interests, GoldHaven Resources also detailed plans for a non-brokered private placement of 11.5 million units at a price of $0.35 per unit, for gross proceeds of $4,025,000. Each unit will consist of one share of the company and one warrant, the latter of which can be exercised to acquire an additional share of the company for a period of 18 months from the date of issuance at a price of $0.50 per share. Net proceeds from the offering are intended to be used to fund general expenses, as well as exploration and drilling of its mineral properties.
Gold Prices Hit Record High in 2020
Gold prices have been on a remarkable run in 2020, breaking above $2,000 per ounce for the first time on record. Having begun the year at $1,515 per ounce, the precious metal has seen a huge surge on the back of widespread economic uncertainty stemming from governments’ worldwide propensity to expand the money supply, from the reduction of the value of the U.S. dollar as expressed by the decrease in the U.S. dollar index, and from the very real economic effects of the COVID-19 pandemic.
Global central banks have carried out 144 interest rate cuts thus far in 2020, reducing rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures has prompted a number of investment banks to boost their near-term outlooks for gold prices, with Bank of America raising its 18-month gold price target to $3,000 per ounce (http://nnw.fm/PQJtc).
Leadership Team
David Smith, President, CEO and Director, has been immersed in the mining industry for the last eight years, working in corporate development and finance. Prior to GoldHaven Resources, Smith cofounded a multifaceted real estate development and sales company, which has now been in operation for over 35 years. He also cofounded two successful environment-focused companies listed on the Toronto Stock Exchange. Both companies were sold independently and returned a significant profit for shareholders.
Darryl Jones, Chief Financial Officer, is a finance executive and CPA with over 30 years of public company and project buildout experience. Most recently, Jones served as the CFO of Lupaka Gold Corp., retiring in June 2018. Prior to that, Jones serves as CFO of Corriente Resources, which was sold to CRCC-Tongguan in May 2010 for C$680 million.
Patrick Burns, VP Exploration and Director, is a Canadian geologist with over 40 years of experience throughout the Caribbean and Central and South America. He played a direct role in the discovery of the Escondida porphyry copper deposit in Chile and has been involved in publicly traded mining companies, predominantly in Chile, for 35 years.
Marla Ritchie, Corporate Secretary, brings over 25 years of experience in public markets to the GoldHaven team. Throughout this time, she has worked as an administrator and corporate secretary specializing in resource-based exploration companies. Currently, Ritchie is the corporate secretary for several companies, including International Tower Hill Mines Ltd. and Trevali Mining Corp.
Gordon Ellis, Director; has over 50 years’ experience in mining and resource development. A professional engineer and entrepreneur, he has held multiple senior management and director roles with public mining companies, as well as a multi-billion-dollar ETF fund. Ellis holds an MBA in international finance and a Chartered Directors designation.
Scott Dunbar, Director is a professor and head of multiple departments at the University of British Columbia, including mineral extraction and mining innovation, as well as mining engineering. He has been involved in projects around the world in regard to mining exploration, geotechnical engineering and mine design. Dunbar received his PhD in geophysics and civil engineering from Stanford University.
GoldHaven Resources Corp. (OTCQB: GHVNF), closed Friday’s trading session at $0.3035, up 6.4912%, on 160,927 volume with 47 trades. The average volume for the last 3 months is 115,376 and the stock's 52-week low/high is $0.109999999/$0.870000004.
Recent News
- Top Manufacturers of Autonomous Haulage Systems for the Mining Industry
- Australian Team Develops Mining Technique That Uses Magnetic Fields Rather Than Digging
- A Few Uses for Silver You Probably Didn't Know
Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)
The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).
Energy Fuels Inc. (TSX: EFR) (NYSE American: UUUU) was featured today in a publication from InvestorPlace, examining how investors are looking for the green energy source of the future.
Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.
As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.
Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:
- White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
- Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
- Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.
In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.
FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.
Nuclear Market Potential
Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.
Reasons Nuclear is Gaining Traction
- Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
- Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
- Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.
No. 1 U.S. Producer of Vanadium in 2019
Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.
Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:
- La Sal Complex (Utah)
- Whirlwind Mine (Colorado/Utah)
- Rim Mine (Colorado)
Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.
Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup
The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.
Management Team
Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.
W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.
David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.
Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.
Energy Fuels Inc. (UUUU), closed Friday’s trading session at $6.07, even for the day, on 2,517,376 volume with 12,280 trades. The average volume for the last 3 months is 4,468,085 and the stock's 52-week low/high is $1.41999995/$7.82999992.
Recent News
- Liquid Electricity Stocks: What to Know If You Want to Invest in the Futuristic "Wonder Fuel"More Green Energy StocksMore From InvestorPlace
- InvestorNewsBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Hosts Q1 2021 Earnings Call
- The Role of Wearable Technology in Mining
Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF)
The QualityStocks Daily Newsletter would like to spotlight Pac Roots Cannabis Corp. (PACR).
Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), dedicated to delivering premium products using a genetics-based approach, is guided by its motto – the Future of Genetics: Quality over Quantity. True to this ideology, PACR has a strategic licensing agreement with Phenome One, a full-service cannabis farming company focused on elite strain-selective breeding. This agreement has provided Pac Roots with unfettered access to one of Canada’s largest live genetic libraries for growing, breeding and cloning use. A recent article reads, “Relying on Phenome’s years of choosing only the most elite genotype and phenotype expressions, Pac Roots is able to offer its customers the highest-quality cultivar possible. Whether it’s a CBD-dominant plant with a rare terpene profile or a soaring 30%+ THC giant, Phenome One has a cultivar suited for every customer.” To view the full article, visit: https://cnw.fm/nWEOG
Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) is a Canadian cannabis company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach.
The company is focused on cannabis and hemp cultivation, leveraging high-end genetics and specialized cultivars to produce top quality products. Pac Roots has announced multiple promising initiatives in recent months since it commenced trading on the Canadian Securities Exchange on May 4, 2020. The company has a partnership with Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars, as well as a JV partnership with Rock Creek Farms and Speakeasy Cannabis Club leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within its first year of trading.
Furthermore, the company recently completed an agreement to acquire all issued and outstanding shares of a firm holding 250 acres of land in the famed Fraser Valley Region of British Columbia.
Pac Roots is also in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through an elite line of 350+ unique, high-grade cultivars. Pac Roots expects to receive a cultivation license for the facility in the fourth quarter of 2020.
High-End Selectively Bred Genetics
Pac Roots focuses on high-end genetics in order to maximize the quality of its products while maintaining high yields and profit margins.
Through the process of artificial selection, farmers and cultivators have been adapting their plants to develop particular phenotypic traits for generations. Historically, this practice was restricted to underground cannabis producers developing their own strains.
The legalization of the cannabis industry has given producers access to thousands of cultivars located throughout the world while accelerating research into cannabis genetics. By carefully selecting strains, growers can control the size, color, smell, density and texture of cannabis buds, thereby creating distinctive, premium cannabis products.
Plants are bred to thrive in specific growing environments. This maximizes the yield of high-quality, resilient cannabis. Medical cannabis strains can also be tailored for specific medicinal purposes.
A strategic partnership with Phenome One, a plant breeding management and analytics firm, gives Pac Roots access to some of the world’s best cannabis genetics from the largest genetic library in Canada. The company is using these genetics to develop unique strains featuring a variety of beneficial characteristics.
The company’s 350+ licensed live cultivars and over 1,800 seed varieties are the result of a meticulous gene selection process, through which as many as 600 individual plants may be grown to produce a single strain. Selecting optimized genetics in this way provides benefits beyond simply producing a high-end product. In addition to potency and bud quality, cannabis plants are bred for yield and resilience. By selecting genetics that result in larger and more numerous buds on each plant, Pac Roots is able to grow more cannabis per grow light.
Breeding plants to be more resilient also reduces the cost and labor required. These factors, combined with the premium price point associated with top-quality cannabis, have the potential to improve Pac Roots’ overall profit margin.
Partnership with Phenome One
Pac Roots has secured its cultivars through a strategic licensing agreement with Phenome One. Under the agreement, Pac Roots has unlimited access to Phenome One’s live genetic library, including any of Phenome One’s cultivars and its growing, breeding and cloning IP.
Phenome One is an agricultural technology company focused on providing software solutions to seed companies. Phenome One’s platform gives its partners access to a massive database of detailed information on over 350 unique cannabis cultivars to support each stage of the breeding process. Each cultivar has been laboratory analyzed and rigorously field-tested, with data going back more than 30 years.
Using Phenome One’s data, Pac Roots plans to grow a variety of cannabis plants optimized for certain traits. One such trait will be plants with an abundance of cannaflavin, a rare terpene with high anti-inflammatory properties. Phenome One’s library could enable Pac Roots to produce plants that are bred to thrive in a range of different growing climates, including plants suited to grow in cold weather and plants that are resilient to region-specific fungi.
Joint Venture with Rock Creek Farms of British Columbia
Pac Roots recently entered a definitive investment agreement with Rock Creek Farms, a reputable agricultural enterprise, for a 100-acre commercial hemp operation in Rock Creek, British Columbia. The growing space is located in the highly lucrative farming area known as the ‘Golden Mile’ in the South Okanagan Valley of British Columbia. (http://nnw.fm/Gbf9I).
Under the agreement, the two companies have formed an outdoor premium hemp joint venture company to which Pac Roots is providing an aggregate of $450,000 in capital and Rock Creek Farms is contributing two commercial leases for 100+ acres of growing space, along with cultivation licenses, agricultural infrastructure and equipment, consulting services, intellectual property relating to hemp operations and proprietary biomass storage methods. Pac Roots holds a 60 percent interest in the project.
About 127,500 premium hemp CBD seedlings were planted across 100 acres as of early July 2020. The joint venture is planting a premium grade CBD hemp variety utilizing the rich native soil and both traditional and custom farming techniques.
“Our operational partners at Rock Creek Farms bring decades of generational farming expertise in one of Canada’s pre-eminent growing regions,” Pac Roots President and CEO Patrick Elliott said in a news release detailing the venture. “It will be an exciting outdoor growing season for the joint venture as we anticipate a successful harvest in the fall.”
Infinite Development Possibilities at Fraser Valley Property in British Columbia
In September 2020, the company announced the closing of a share purchase agreement with 1088070 BC. LTD. (“1088”) and its shareholders for the acquisition of all issued and outstanding shares of 1088 (https://nnw.fm/9gXHk). Through this agreement, Pac Roots gained ownership and control of 250 acres of land spread over nine parcels in the Fraser Valley Regional District.
The Fraser Valley Regional District is one of the most productive and intensively farmed areas of Canada, offering access to high-quality soil, favorable climate, water and a local market of 2.5 million people. Agriculture in this region yields an annual economic value of more than $3 billion.
According to Elliott, the addition of such a significant package of land is a major step for Pac Roots.
“The addition of such a substantial package of land to our portfolio is a major step for Pac Roots. We are pleased to have the opportunity to add significant acreage with an acquisitional cost base of $9,600 per acre. This land has no zoning restrictions and is not situated within the Agricultural land reserve, which provides for infinite development possibilities,” Elliott added in the September 2020 news release.
Board of Directors member Chad Clelland also welcomed the acquisition, adding that between Fraser Valley and Rock Creek – both of them among the most productive agricultural regions in Canada – Pac Roots is very well positioned for production and the future development of its hemp and cannabis infrastructure.
The RAD Americas Genetic Program – Research and Development in Americas Genetic Program
Pac Roots intends to deploy a global R&D program focused on rigorously testing elite strains in various rich agricultural regions throughout the Americas, with a goal of mass selection to achieve the utmost environmental resilience while achieving notable quality and yields. From seed to software, collection data, proprietary techniques and custom nutrient formulas, Pac Roots and Phenome will provide the specific knowledge to cultivators in different climates in order to achieve optimal yields for THC, CBD, CBG and other unique cannabinoids. R&D from global testing programs situated throughout the Americas will allow the partnership to deploy and stress test a range of suitable cultivars in the world’s lowest cost outdoor growing regions.
The company expects an industry shift in 2020 from the COVID-19 global pandemic. The ‘new normal’ will bring more focus on efficiencies and optimal yields to deliver a cost effective, high quality product to the end user. There has been much to be learnt from the inefficiencies in the cannabis industry in recent years, which have been detrimental to the credibility of the sector. Pac Roots is well positioned to enter the scene and take advantage of the deficiencies, reinforcing the notion that genetics and flawless growing techniques are paramount to success. Genetics and systems innovation may be the most overlooked components when comparing cannabis to other established agricultural crops. Pac Roots plans to invest into cannabis R&D to ensure a solid foundation is built that will be used by cannabis farmers worldwide.
Through its RAD Americas Development and Innovation, Pac Roots is focused on:
- Deploying one of the largest live genetic libraries in Canada, diversified for high yield output and unique climates
- Continued stress testing for indoor, high yield, THC and medicinal genetics
- Continued stress testing for outdoor, high yield, THC and medicinal genetics
- Exotic, genetic cloning for the luxury, high margin, cannabis flower market
- Psychoactive/medicinal ratio testing for effect and
- Unique Cannabinoid and terpene elevation and isolation.
Through its RAD Americas Field Testing System, the company is focused on:
- Global testing in different microclimates to assess genetic and complete systems for optimal yields
- Data collection, testing and optimization to prove process for commercial implementation and
- High quality yield testing for THC, CBD, CBG and other unique medicinal cannabinoids.
Lake Country Cultivation Facility near Kelowna, British Columbia
Pac Roots is in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through its line of high-grade cultivars. Pac Roots plans to submit a video evidence package of the facility build under Health Canada’s Cannabis Tracking and Licensing System, and the company expects to acquire its cultivation license in the fourth quarter of 2020.
Lake Country is a municipality located just outside of Kelowna in the Okanagan region of British Columbia. For decades, the region’s favorable growing climate has made it a hub for cannabis cultivation. As the Canadian legal cannabis industry ramps up, the Okanagan region is attracting attention from dozens of cannabis companies, including some of the industry’s biggest names. The region’s strong agricultural history has left it rich with experienced agricultural workers and an abundance of Agricultural Land Reserve (ALR) property.
Management Team
Patrick Elliott, MSC, MBA, President and CEO of Pac Roots Cannabis, is also the President & CEO of Lexore Capital Corp., a private resource and cannabis investment company, as well as Phenome One Corp., a full-service cannabis farming company focused on elite strain selective breeding. Elliott brings over 15 years of corporate finance, mineral exploration and financial markets experience to the Pac Roots team. He is a graduate of the University of Western Ontario in geology and holds an MSc. in mineral economics and an MBA from Curtin University of Technology in Perth, Australia. Elliott specializes in economic resource evaluation, financial modeling, CAPEX estimation, corporate development and finance. Combined with his technical knowledge, Elliott has a wealth of contacts in the financial sector.
Marc Geen, Founder and Strategic Operations Advisor, is a fourth-generation British Columbia farmer who has been active in the legal medical marijuana industry for more than 10 years – consulting on, complying with, and participating in the MMAR, MMPR and ACMPR programs. Prior to co-founding Speakeasy Cannabis Club Ltd., Geen spent 14 years as Head of Operations for Kettle Mountain Ginseng Ltd., one of North America’s largest ginseng producers. With the experience gleaned from a long career in large scale commercial farming, Geen has been able to apply many cost-effective farming practices to the outdoor, indoor and greenhouse cultivation of cannabis. Geen is also the co-creator of a full line of cannabis extract products designed under ACMPR regulations.
Matt McGill, Director, has a strong background in both commercial and residential real estate and has played a major role in many development projects. McGill, through McGill Realty, has established a tremendous commercial and residential outfit servicing British Columbia’s Fraser Valley and the lower mainland. McGill is skilled at crafting strategic financing options for corporations and has a substantial network of retail and institutional clients.
Chad Clelland, Director, has experience in the sector dating back to 2009, when he purchased Medicalmarijuana.ca, which became an information portal for thousands of patients, doctors and growers. Through this company, he and his team have helped thousands of Canadians find legal, safe medication. His team also consulted, designed and submitted dozens of applications to the government under the MMPR, ACMPR and Cannabis Act. In 2011, Clelland co-founded Greenleaf Medical Clinic, which is now recognized as a training facility by the University of British Columbia and offers preceptorships to physicians, nurse practitioners and pharmacists. He also co-founded Folium Life Science in 2013, an approved Canadian Licensed Producer. His roles in these organizations have included Chief Operating Officer, head of security, alternate master grower and alternate responsible person in charge.
Josh Bromley, Senior Cultivation Strategist, is a second-generation farmer with over two decades of experience farming, breeding, cultivating and selecting unique cultivars for the medical community. He is an expert in plant science and possesses a comprehensive knowledge of cultivars and a mastery of medicinal implementation. Bromley has developed proprietary farming systems, as well as low cost/high output nutrient systems. Through thoughtful design and engineering, he has been able to consistently show improvements in crop yields, pathogen resiliency and quality.
Pac Roots Cannabis Corp. (PACRF), closed Friday’s trading session at $0.1532, even for the day, on 10 volume. The average volume for the last 3 months is 3,078 and the stock's 52-week low/high is $0.009999999/$0.204500004.
Recent News
- CannabisNewsBreaks - Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Continues to Espouse 'Future of Genetics: Quality over Quantity'
- Pac Roots Cannabis Corp.'S (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Focus on Premium Genetics, Iconic Branding Differentiates Products in Competitive Marketplace
- Pac Roots Cannabis Corp.'S (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Focus on Premium Genetics, Iconic Branding Differentiates Products in Competitive Marketplace
Aterian, Inc. (NASDAQ: ATER)
The QualityStocks Daily Newsletter would like to spotlight Aterian, Inc. (ATER).
Aterian (NASDAQ: ATER), a leading technology-enabled consumer products platform that builds, acquires, and partners with best-in-class e-commerce brands, announced that key management personnel participated in the 16th annual Needham Technology & Media Conference. Participants included co-founder & CEO Yaniv Sarig and CFO Arturo Rodriguez. The two ATER leaders were interviewed by Needham senior analyst Anna Andreeva during a key segment of the May 17, 2021, event. During the fireside chat, the pair discussed a variety of topics, including ATER’s corporate strategy. The discussion also covered how the company’s exclusive technology-enabled software platform AIMEE operates and how it impacts the success of not only ATER’s organic growth but also its acquisition strategy. The announcement also included the company’s plans to participate in the Jefferies Consumer & eCommerce Summit on May 25, the RBC Capital Markets Global Consumer & Retail Conference on June 2, and the Jefferies Virtual Consumer Conference & Digital Gaming Day on June 22. To view the full press release, visit https://ibn.fm/YL0QA.
Aterian, Inc. (ATER) is a leading tech-enabled consumer products platform that uses machine learning, natural language processing and data analytics to design, develop, market, and sell products. The company’s proprietary AIMEE(R) platform leverages data and AI to automate the design, development and launch of best-selling consumer products.
Aterian owns and operates 12 brands and sells consumer products in multiple categories ranging from kitchenware and home appliances to environmental appliances, beauty products and even consumer electronics.
Founded in 2014, Aterian has offices in the United States, Canada, China and the Philippines. The company is always working to capitalize on the strength of the different cities and time zones in which it operates to ensure continued excellence around the world and achieve its goal of becoming the most consumer-centric product company.
AIMEE(R) Platform
AIMEE(R) (AI Aterian E-commerce Engine) is Aterian’s proprietary platform that leverages data and AI to:
- Identify new market opportunities;
- Launch new products;
- Automate marketing variables; and
- Analyze and optimize company-owned and operated consumer product brands.
The platform’s core functionalities include:
- Research: Automated research using live market data that tracks exposure and product trends, allowing for the swift discovery of new market and product opportunities;
- Financials: Places data insights in one place, enabling execution across multiple channels to track new product planning, financial projections, inventory levels, media buying and more;
- Trading: The result of an algorithmic solution that has been optimized for live decisions to scale sales and built to implement automated marketing strategies with learning through experimentation; and
- Logistics: Manages logistics to enable faster delivery of products to consumers.
Aterian’s Business Model
Aterian’s unique business model is designed to drastically shorten go-to-market time, decreasing the typical 18- to 24-month process to just 6- to 8-months. Using AIMEE(R), Aterian leverages real-time data-driven opportunities and trend tracking to replace the idea focus group research and development of the standard model.
Marketing time is also reduced between the two models using the AIMEE(R) Trading Engine for data-driven automated marketing and product lifetime management. Through the AIMEE(R) trading engine, the traditional 3-month marketing for a standard go-to-market model is cut to a fraction of the time.
The AIMEE(R) Fulfillment Engine allows for dynamic inventory allocation, fulfillment selection, cost optimization, a third-party logistics network and a 2-day shipping period across almost all of the United States. The standard business model doesn’t support direct distribution or an FBA (fulfilled by Amazon) structure.
Opportunities for Growth and Profitability
Aterian’s plan to drive growth and profitability in the market includes:
- The continued optimization of product economics by lowering manufacturing and logistical costs through an increase in purchasing power
- The pursuit of higher-value products with larger target markets
- Opportunistically adding new products and categories through acquisitions
- Expansion into the international and new domestic e-commerce marketplaces
- Monetization of its proprietary AIMEE(R) platform by providing access to third-party brands
Aterian’s long-term goal is to increase its profit margin from 14% in 2020 to 18-20%, using higher average selling prices and lower fulfillment costs as primary drivers. Due to its technology and platform effect, Aterian’s corporate overhead is expected to increase at a slower pace than sales. Its fixed operating costs long-term target goal is 5%, which follows the current trend (2019 – 19%, 2020 – 13%). It aims for an adjusted EBITDA of 13-15%.
Management Team
Yaniv Sarig has been Aterian’s President and Chief Executive Officer since September 2018. He is also a co-founder of Aterian Group Inc. Mr. Sarig has served as the President and Chief Executive Officer of Aterian Group Inc. since June 2014. Before his role at Aterian, he led the Financial Services Engineering department at Coverity, a software startup providing code and security solutions to top financial institutions and hedge funds in New York to include the New York Stock Exchange, Nasdaq, JPMorgan Chase and Barclays. Before his Coverity role, Mr. Sarig held lead technical roles at Bloomberg and EPIQ Systems Inc. (NASDAQ: EPIQ). He holds a Bachelor of Science from Touro College. He is fluent in English, French, Hebrew and C++.
Fabrice Hamaide has been the Chief Financial Officer of Aterian since September 2018. He has also retained the position of Chief Financial Officer for Aterian Group Inc. since July 2017. Before Aterian, Mr. Hamaide held numerous financial, CFO and presidential roles in various technological and consumer product companies across Europe and the United States, including Piksel Inc., Atari, Parrot and Logitech. Mr. Hamaide holds an impressive set of credentials, including an MBA from Columbia Business School, an MS in Information Systems Design from Sorbonne University, and a BS in Applied Mathematics from Jussieu University.
Mihal Chaouat-Fix has been the Chief Product Officer for Aterian since September 2018. Prior to taking this role within the company, she was the Chief Operating Officer, handling the day-to-day leadership and operational management of Aterian. Before joining Aterian, Ms. Chaouat-Fix worked in various roles at Gottex Models Ltd. At this international fashion swimwear firm, her focus on marketing, operations and manufacturing saw supply chain and distribution of 12 million units per year to over 40 countries worldwide.
Tomer Pascal has been the Chief Revenue Officer for Aterian since 2018. He has also served as the Chief Revenue Officer for Aterian Group Inc. since 2017. Before he joined the Aterian team, he was the Chief Executive Officer and co-founder of OMG Studios. Throughout his career, Mr. Pascal has held many different co-founder and general management roles, focusing on companies’ marketing and revenue growth in the media and technology industries.
Roi Zahut has held the role of Chief Technology Officer for Aterian since 2019. Before Aterian, he served in numerous roles, including CTO of the Advanced Analytics global consulting team at IBM and architect of IBM Metropulse. While in Israel, Mr. Zahut held several senior technical, business and data science roles in startups and consulting to include IBM Israel, Brainbow Ltd. and Matrix IT Ltd. He holds an MSc in Neuroscience with distinction from Bar Ilan University.
Aterian, Inc. (ATER), closed Friday’s trading session at $17.04, off by 0.46729%, on 1,038,242 volume with 8,303 trades. The average volume for the last 3 months is 1,141,861 and the stock's 52-week low/high is $4.1999998/$48.9900016.
Recent News
- InvestorNewsBreaks - Aterian Inc. (NASDAQ: ATER) Announces Execs Participation in Tech & Media Conference; Upcoming Conferences Outlined
- Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayPre-Market Stock Movers: 10 Top Gainers10 Top LosersMore From InvestorPlace
- Investors Who Have Lost Money in Their Aterian, Inc. Investment Should Contact Block & Leviton, Who Is Investigating Potential Securities Fraud Claims Against Aterian
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)
The QualityStocks Daily Newsletter would like to spotlight XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT).
XPhyto Therapeutic Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) was featured today in the 420 with CNW by CannabisNewsWire. Last month, New York Gov. Andrew Cuomo approved a legislation legalizing marijuana and its possession for individuals aged 21 and above in the states. However, the substance will not be available for legal sale until 2022. The governor and his aides expect that this move will create 60,000 employment opportunities while generating roughly $350 million in tax revenue once the industry’s up and running.
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. This includes products that are being readied for commercialization within the coming weeks, such as a rapid COVID-19 PCR test kit that reduces turnaround times to less than 30 minutes.
The company has research and development operations in North America and Europe and an operational focus in Germany. Its regulatory approval and commercialization focus is currently on products for the European market.
XPhyto was founded in 2017 and is headquartered in Vancouver, British Columbia.
Business Strategy & Milestones for 2021
On January 18, 2021, XPhyto issued a news release detailing its business strategy for the coming year. The company noted that it is “on the cusp of transformational change as product development programs advance from the laboratory to the clinic.” In addition to continuing to leverage its scientific expertise and operations in North America and Europe for product development and optimization, XPhyto intends to pursue growth through the commercialization of existing products and adherence to a focused investment strategy targeting impact-driven innovation with “the potential for extreme value creation.”
In particular, XPhyto is well positioned to execute on opportunities across its current business divisions, including:
- Commercialization of infectious disease diagnostics
- Clinical validation of transdermal and sublingual drug formulations
- Continued investment and development in psychedelic medicine
“2020 was a very productive year for XPhyto. We made significant progress in all areas of our business,” Hugh Rogers, CEO & Director of XPhyto, stated in the update. “We have ambitious milestones for 2021 with multiple product launches on the horizon, multiple clinical drug programs underway, and an aggressive commitment to psychedelic medicine. I am extremely confident that our team can execute on the company’s business plan for 2021.”
Infectious Disease Diagnostics
XPhyto’s lead diagnostic product, secured through an exclusive global commercialization agreement with 3a-diagnostics GmbH (“3a”), is a rapid and highly portable PCR diagnostic test. Notably, PCR testing “has emerged as the only internationally recognized standard for COVID-19 testing” and is expected to play a key role in facilitating the recovery of the domestic and international travel industries, among others.
Successful validation of the PCR system was achieved in Q4 2020, and XPhyto has expressed confidence that it will achieve European commercial (CE-IVD) approval in Q1 2021. In preparation for this milestone and an anticipated Q1 product launch, the company is currently in discussion with manufacturing and distribution partners in Europe and the Middle East.
In addition to COVID-19 products, XPhyto and partner 3a are developing and commercializing a portfolio of low-cost oral biosensors. The company’s lead biosensor product is an oral health screening test for the detection of peri-implantitis for which XPhyto is targeting a late 2021 European commercial approval.
XPhyto does not make any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic.
Drug Formulation & Delivery
In 2020, XPhyto’s German subsidiary, Vektor Pharma TF GmbH (“Vektor”), reported significant advancement in four therapeutic programs targeting neurological indications with significant market demand. Vektor also successfully developed a sublingual drug formulation on contract for a major generic drug manufacturer and distributor.
XPhyto will look to build on this progress in 2021, with plans to complete human pilot studies evaluating its four lead therapeutic products:
- Rotigotine transdermal patch for Parkinson’s disease
- CBD oral/sublingual strip for treatment resistant epilepsy
- THC oral/sublingual strip for anorexia/nausea
- CBD:THC (1:1) oral/sublingual strip for multiple sclerosis associated spasticity
Per its 2021 business update, the company is currently in “ongoing discussions with multiple potential commercial partners, licensors and distributors and will be reviewing monetization opportunities on a continued basis.”
Psychedelic Medicine
Psychedelic compounds are a highly promising new class of active pharmaceutical ingredient (“API”) demonstrating strong potential for a variety of mental health conditions. XPhyto is positioned to capitalize on this promise through two strategic initiatives:
- An agreement for the development of industrial scale biotechnology processes for the production of psilocybin
- An agreement for R&D related to multiple psychedelic compounds, including psilocybin, mescaline, LSD, MDMA and DMT, among others
XPhyto intends to advance and expand its programs focused on the industrial scale production of psychedelic API in 2021. The company also plans to launch new programs for the development of psychedelic drug formulations, with a focus on sublingual and transdermal therapeutics and the integration of these products into established clinical programs relating to mental health indications.
Management Team
Hugh Rogers is the CEO and Director of XPhyto Therapeutics Corp. He is an entrepreneur and lawyer with private and public start-up company experience in various industries and operational roles. His recent advisory work has focused on public listings and corporate restructuring. This restructuring has occurred in the life science (cell therapy and medical device) and natural resources (natural gas co-gen and conventional oil) industries. Mr. Rogers holds a bachelor’s degree in Cellular Biology and Genetics and a law degree. He is a member in good standing of the Law Society of British Colombia.
Christopher Ross is the CFO of XPhyto. He is a professional accountant with broad financial experience across numerous industries, including forestry, distribution, construction, mining and multi-family real estate. He has provided advisory services to private and public companies in the areas of financial accounting, strategic analysis, audit and taxation. Mr. Ross holds a bachelor’s degree in commerce. He is a member in good standing with the Chartered Professional Accountants Association of British Columbia.
Wolfgang Probst serves as Director of XPhyto and Managing Director of BUNKER Pflanzenextrakte GmbH. He is a seasoned management and financial consultant based in Bavaria, Germany. He has consulting experience as branch head working with private clients and corporations of high net worth. In 2017, Mr. Probst assumed the CFO role of BUNKER and continues to play a key role in its operational and financial development.
Professor Dr. Raimar Löbenberg serves as Director of XPhyto. He holds a Bachelor of Science in pharmacy from Johannes Gutenberg-University and a Ph.D. in pharmaceutics from the Johann Wolfgang Goethe-University. He is the co-founder of RS Therapeutics Inc., which concentrates on foam-based topical drug delivery systems.
Professor Dr. Thomas Beckert is the Founder and Managing Director of Vektor Pharma TF GmbH. His expertise includes the formulation and machine development of transdermal therapeutic systems and ODFs. Professor Beckert holds a Bachelor of Science in pharmacy from the University of Freiburg and a Ph.D. in pharmacy and economics from the University of Tubingen.
XPhyto Therapeutics Corp. (OTCQB: XPHYF), closed Friday’s trading session at $1.8529, off by 1.1418%, on 68,942 volume with 117 trades. The average volume for the last 3 months is 57,741 and the stock's 52-week low/high is $1.3125/$3.0999999.
Recent News
- 420 with CNW - How the State of New York Plans to Tax Marijuana
- InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Proprietary Covid-ID Lab to Launch in Germany
- First Psychedelics Training Program Targeting Canadian Mental Health Workers Ends Successfully
Brain Scientific Inc. (OTCQB: BRSF)
The QualityStocks Daily Newsletter would like to spotlight Brain Scientific Inc. (OTCQB: BRSF).
Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company providing next-gen solutions to the neurology market, is poised to offer a response to brain diagnostic challenges in the hospitals' red zones amid the pandemic. As the Company describes in one of the recent articles published on the website, the consequences of the COVID-19 pandemic on brain health are significant (https://ibn.fm/fhYxm). Also today, the company was featured in a publication from BioMedWire, examining how recent research that was presented at the 70th Annual Scientific Session, which is held by the American College of Cardiology, has found that middle-aged and young adults who have been diagnosed with conditions such as anxiety or depression after they’ve suffered cardiac arrest have twice a higher chance of suffering from a second heart attack when compared with individuals who experience mild levels of distress.
Brain Scientific Inc. (OTCQB: BRSF) is a commercial-stage health care company focused on developing innovative and proprietary medical devices and software. With a mission of modernizing brain diagnostics by employing cutting edge technologies to bridge the widening gap in access to quality care, the company offers two FDA-cleared products that provide next-generation solutions to the neurology market.
The company’s proprietary, clinical-grade neurological devices are supported by its intellectual property portfolio featuring patents in the United States, China and Europe.
Brain Scientific’s first commercialized devices, NeuroCap(TM) and NeuroEEG(TM), are designed to disrupt the current electroencephalogram (EEG) market by offering cost-effective and disposable substitutes to existing solutions, allowing medical professionals to collect diagnostic information quickly.
The company’s goal is to improve diagnostics by leveraging artificial intelligence and machine learning processes to analyze a database of brain readings as a method of detecting seizures and dementia. The company is also working to improve patients’ access to neurological care.
Headquartered in New York, Brain Scientific and its predecessor (and now wholly owned subsidiary, MemoryMD Inc.) was founded in 2015 and went public in 2018.
Brain Scientific’s first phase of development, from 2018 to 2019, saw the inception of portable, clinical-grade, easy-to-use neurological devices. The second phase, currently ongoing, aims to create cloud-based, secure infrastructure to transmit patient data between patients and their neurologists. The company’s third phase of development is scheduled for 2021-2022 and is expected to focus on the use of AI-assisted diagnostic analysis to increase the efficiency, consistency and accuracy of neurology specialists.
NeuroCap(TM) – Disposable EEG Headset
The NeuroCap is a disposable pre-gelled EEG headset featuring 22 electrodes and 19 active EEG channels, all adhering to the international 10-20 system. The NeuroCap was FDA-cleared in 2018. The headset can be used for recording EEGs in virtually any setting, including urban and rural emergency departments, neurology clinics, urgent care clinics, ICUs, nursing homes, assisted living facilities and remote clinical research labs.
Through a universal cable adapter, the NeuroCap is compatible with other EEG amplifiers. The cap also works in parallel with Brain Scientific’s NeuroEEG amplifier, initiating EEG studies in less than five minutes.
The company is currently seeking FDA approval for additional features for the NeuroCap, as the device has the potential to fill a gap in EEG testing availabilities during the current coronavirus pandemic: in October 2020, Brain Scientific filed an Emergency Use Authorization (EUA) application. The EUA is required for the rapid distribution of the NeuroCap device to emergency departments, intensive care units and other treatment centers to administer prescriptive EEGs safely on critically ill patients or those suspected of being diagnosed with COVID-19.
With more than 80 percent of hospitalized patients infected with COVID-19 displaying neurological symptoms, the NeuroCap could prove to be a valuable device by offering fast testing with limited contact between technicians and patients.
NeuroEEG(TM) – Miniature and Portable Wireless EEG Amplifier
The NeuroEEG is a compact, portable and affordable wireless EEG amplifier intended for prescription use. The 16-channel, FDA-cleared, clinical-grade device acquires, records, transmits and displays electrical brain activity for patients of all ages.
Both the NeuroCap and NeuroEEG are delivered by MemoryMD Inc., a wholly owned subsidiary of Brain Scientific.
Products in Active Development
Currently, Brain Scientific and MemoryMD are working on leveraging their existing products and drawing from ongoing research to develop and commercialize the next generation of solutions for the brain diagnostics market. The devices under development are being designed to address the following issues:
Routine EEG
- NeuroCap-8 is an 8-channel EEG cap. The reduced number of electrodes is vital in emergency room situations, where the time it takes to set up the EEG is critical.
Pediatric EEG
- NeuroCap Pediatric is positioned to become the first disposable and pre-gelled headset available for the pediatric market.
Long-Term Monitoring
- NeuroCap LTM for adult and pediatric patients is a disposable cap designed to monitor rhythmic and periodic patterns for up to 72 hours, providing essential diagnostic capabilities.
- NeuroEEG 24 Channel Amplifier is a portable and wireless amplifier with over 24 hours of battery life.
Artificial Intelligence
- Brain E-Tattoo is a minimally invasive four-channel EEG electrode designed for long-term monitoring.
- An AI database of brain biomarkers collects data on both normal and abnormal brain data to detect neurological diseases. The goal is for machine learning algorithms to enhance understanding of brain-behavior related to epilepsy, memory dementia and pre-Alzheimer’s diagnostics.
Telemedicine
Brain Scientific is expanding the vision for telemedicine in neurology. The company aims to address the current acute neurologist shortfall (20 states have less than 10 neurologists per 10,000 patients) through the use of teleneurology.
Partnership with Marketing Brainology
Brain Scientific has a longstanding partnership with Marketing Brainology, a neuromarketing firm using neuroscience approaches to understand consumer behavior. In 2019, Marketing Brainology conducted a study using NeuroCap and NeuroEEG to determine the most effective Super Bowl commercials.
“Thanks to Brain Scientific’s NeuroCap and NeuroEEG, we are able to better understand the art and science of the human decision-making process,” Michelle Adams, Ph.D, Founder of Marketing Brainology, stated in a news release.
In April 2020, Marketing Brainology again conducted a study leveraging Brain Scientific’s disposable EEG cap to determine how brains were reacting to COVID-19 messaging. Subjects were presented with multiple media impressions, and Marketing Brainology analyzed their responsive biomarkers. The results identified the most effective messaging for engaging with an audience during a crisis.
Market Outlook
The current global market for EEG devices is estimated at $956.1 million. It is expected to rise with a CAGR of 8.7% from 2019 to 2026, reaching $1.6 billion in value by 2026, according to Grandview Research.
In total, there are approximately 6,150 hospitals in the U.S., according to the American Hospital Association. Critically, though, just 254 of those hospitals are certified Level 4 Epilepsy centers with 24/7 EEG coverage. Since very few non-Level 4 centers have extensive EEG tech coverage, this creates a significant opportunity for Brain Scientific to bridge the gap by providing over 5,900 hospitals with lower cost amplifiers and disposable EEG caps.
The company also see opportunities to work with other businesses, such as EEG manufacturers hoping to package Brain Scientific’s solutions with their products, which could greatly expand Brain Scientific’s addressable target market.
Management Team
Dr. Baruch “Boris” Goldstein, Ph.D., is co-founder and Chairman of Brain Scientific. He is a seasoned executive with a proven talent for aligning global business strategies with established and emerging management teams. Goldstein’s growth-focused leadership style has helped him raise over $750 million in venture capital for the development of innovative companies and startups in diverse industries, including financial services, biomedicine, alternate energy and new materials, as well as groundbreaking work in artificial intelligence. His recent achievements include important advancements in neurology and unlocking the potential of AI correlations and machine learning applied to life sciences and medical research. He built a suite of first-to-market companies as a technology-oriented leader, including Ryah Medtech, Brain Scientific, GrapheneCA, E-Forex and Intelligent Video Systems. He also co-founded BrainRX, a company specializing in pre-Alzheimer’s diagnostics.
Dr. Nikolay Kukekov, Ph.D., is a Director of Brain Scientific and a partner at HRA Capital. Before joining HRA Capital, Kukekov was Managing Director of Healthcare Investment Banking at Summer Street Research. His scientific background includes a bachelor’s degree in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder. He earned his Ph.D. in neuroscience from Columbia University – College of Physicians and Surgeons in New York.
Stuart Bernstein is the company’s Vice President of Marketing. He was recently named to the role after spending the first part of his professional career in senior technical management roles with Fortune 500 companies such as NCR (NYSE: NCR), IBM (NYSE: IBM) and Control Data Corp. He was the CEO of BioSignal, an EEG medical device company. He is also a co-founder of several software engineering and telemedicine firms. One of them, Brain Saving Technology, is now Specialist on Call (SOC Telemed) – a leading telemedicine company that powers over 850 facilities for teleneurology, telepsychiatry and critical care telemedicine with over 200 physicians.
Brain Scientific Inc. (OTCQB: BRSF), closed Friday’s trading session at $0.875, off by 1.6854%, on 2,023 volume with 8 trades. The average volume for the last 3 months is 8,390 and the stock's 52-week low/high is $0.550000011/$2.29999995.
Recent News
- Brain Scientific Inc. (BRSF) Committed to Expand Access to Neurological Care for Infected Patients Amid the Pandemic
- Study Finds That Mental Health is Essential in Recovery from Cardiac Events
- Brain Scientific Inc. (BRSF) Offers Solutions for COVID-19 EEG Accessibility
HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF)
The QualityStocks Daily Newsletter would like to spotlight HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF).
HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness company offering premium probiotic supplements and products containing CBD, commends the Hemp Access and Consumer Safety Act filed by Oregon Democratic Senators Ron Wyden and Jeff Merkley and Kentucky Republican Senator Rand Paul. The act aims to add hemp, hemp-derived cannabidiol or a substance containing any other ingredient derived from hemp to the definition of dietary supplement according to the Federal Food, Drug and Cosmetic Act and would remove certain restrictions that have blocked the emergence of legal consumable hemp products in the United States. “HempFusion is prepared for both GRAS (Generally Recognized as Safe) and NDIN (New Dietary Ingredient Notification), which separates us from the vast majority of CBD brands on the market today,” said Dr. Jason Mitchell, HempFusion’s co-founder and CEO. “We proudly endorse and commend The Hemp Access and Consumer Safety Act and thank Senators Wyden, Paul and Merkley for their bipartisan support. A major component of our strategic business plan has been to prepare for this day, and now we are finally at the door of what will open up the CBD industry for those brands that can properly adhere to FDA’s requirements.” To view the full press release, visit https://ibn.fm/NO5du
HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF) is a leader in the health and wellness CBD industry, providing innovative and diversified proprietary formulations utilizing the power of whole-food hemp nutrition.
Invested heavily in regulatory compliance, HempFusion aims to consistently meet and even exceed the high standards required by retailers and consumers – putting safety, quality and consistency first. In support of these efforts, the company is U.S. Hemp Authority Certified and is a current board member of the U.S. Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products.
HempFusion reported 1,750 shareholders and $18.3 million in cash as of June 30, 2020 – the second-largest cash position in its sector – with no debt. Looking ahead, the company is currently preparing to launch an IPO directly onto the Toronto Stock Exchange (“TSX”) senior board, where it has already reserved ticker symbol ‘CBD.U’. Learn More About HempFusion Upcoming IPO.
HempFusion is headquartered in Denver, Colorado.
HempFusion’s Proprietary Wellness Portfolio
The diverse product portfolio showcased by HempFusion includes 46 products that are currently on shelves. The company’s leading offerings include HempFusion-owned Biome Labs, HF Labs and Probulin. Due to the time and resources allocated to increasing the compliance of these proprietary products, HempFusion may have a competitive advantage and create additional retail opportunities that are not available for other CBD companies.
HempFusion’s Diversified Revenue Pipeline
HempFusion’s focus and investment into regulatory compliance has opened doors to major food and drug mass or big box retailers that are not available to other CBD companies. This strategic approach includes five distinct channels:
- Natural Health Retailers
- eCommerce
- Big Box / Food and Drug Mass
- Doctor Practitioner
- Convenience
HempFusion’s Line of Products
HempFusion’s branded line of products is based on the company’s proprietary Whole Food Panoramic Full-Spectrum Hemp Complex. Each product is condition-specific, targeting needs such as sleep, energy and stress.
All of HempFusion’s products are made from DNA-verified, European Union registered, non-GMO, organic industrial hemp. The company’s offerings span multiple product categories, including:
- Tinctures and capsules – These offerings make up the most popular product category in the $4 billion U.S. CBD market.
- OTC topicals – HempFusion is one of the few CBD companies marketing FDA Drug Listed Topicals. The FDA compliance standards ensure that these products meet the standards set by larger national retailers.
- Condition-specific OTC products – HempFusion has OTC products that are condition-specifically targeted, including:
- OTC Pain Products – The global pain relief market for topicals is projected to reach $13.3 billion by 2025, with a CAGR from 2018 to 2025 of 7.4%.
- OTC Eczema Products – The global dermatitis market is projected to reach $13.6 billion by 2026.
- OTC Acne and Aging/Beauty Products – The global market for beauty and anti-aging products is currently estimated at $1.08 trillion.
- OTC First Aid and Wound Healing Products – In 2019, the 10 top-selling first aid ointments in the United States generated over $650 million in sales.
Probulin Probiotics and Digestive Enzymes
Probulin Probiotics is a 100% wholly owned subsidiary of HempFusion Wellness Inc. and is currently one of the fastest growing probiotics brands in the United States, according to Spins syndicated data.
The Probulin product line addresses a wide range of consumer needs, including daily care, total care, women’s health and children’s products. The probiotics market represents a growing opportunity, as it is estimated to reach $7 billion globally by 2022.
Because of the diverse offerings of the Probulin line, it serves as HempFusion’s gateway to retailers who may not currently carry CBD products.
This ‘Trojan Horse Strategy’ is intended to allow the company to establish, develop and build relationships among these retailers. By achieving approved vendor status, the company may be able to facilitate faster onboarding times, enabling accelerated access to its CBD products in the future.
HF Labs and Biome Research – Doctor and Practitioner Product Lines
The HF Labs and Biome Research product lines are directed toward doctors and practitioners and cater to hospitals, compounding pharmacies and free-standing dispensaries. With an estimated target market of 28,000+ integrative medical doctors and 70,000+ licensed chiropractors in the United States, these offerings create a unique market opportunity as HempFusion continues to broaden its footprint in the CBD industry.
Research on CBD and Human Safety
HempFusion is one of 12 CBD companies selected to participate in ValidCare’s groundbreaking study regarding CBD and human safety, which is expected to be complete by the end of October 2020. The study is designed to address previous questions from the FDA regarding CBD products.
As part of this study, HempFusion and the other selected companies will be conducting human trials to determine if the daily use of full-spectrum hemp-derived CBD or CBD isolate impacts the human liver.
Management Team
Jason Mitchell, N.D., is the co-founder, Director and CEO of HempFusion. He has over 20 years of experience in the natural products industry and is a naturopathic doctor certified by the ANMCB. Mitchell received his doctorate from the Trinity College of Natural Health and is a member of the American Naturopathic Medical Association and the CNHP. He is an expert in supplemental formations and was responsible for successfully creating and launching over 300 industry-leading products during his 15-year tenure at Country Life Vitamins.
Ian DeQueiroz is the Chief of Brand Strategy & Partnerships and a Director for HempFusion. He is a serial entrepreneur with experience in early-stage cannabis and hemp companies. In 2010, he acquired his first cannabis CO2 extraction company in the United States. DeQueiroz has facilitated the licensing process for many companies in the United States, as well as one of Jamaica’s premier cannabis companies, Epican Medicinals Ltd.
Jon Visser is HempFusion’s Chief Revenue Officer. He has over 25 years of experience in all areas of sales and marketing, with a proven track record of consistently driving growth across all major channels. Visser was previously the Senior Vice President of Sales at Navajo Inc., a multi-national manufacturer/distributor of brands like Pennzoil Automotive Supplies, Piranha Eyewear and Navajo Inc., the largest distributor of trial- and travel-sized health and beauty products in the United States. Visser grew annual sales from $60 million to $128 million in less than three years while at Navajo Inc.
Bruce Valentine Jr. is the Chief Financial Officer of HempFusion. He has a proven track record working with high-growth companies and was named CFO of the Year in 2013 by the Northern Colorado Business Report. Valentine is the former CFO of Otter Products and has over 15 years of financial management experience.
Ola Lessard is the Chief Marketing Officer of HempFusion and is also the President of the U.S. Hemp Roundtable. She has experience in marketing creative and effective brand strategies. She is a former Vice President of Marketing at Barlean’s, an award-winning supplements provider based in Washington.
Nancy Angelini is the Director of the Doctor/Practitioner Channel. She has over 25 years as an active, licensed practitioner. Angelini travels the country as a lecturer and product manager. She is responsible for opening doors to some of the largest doctor/practitioner networks in the United States.
Daniel Brody is the Chief Corporate Officer of HempFusion. He is the co-founder and former Vice President of The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF). Brody has been instrumental in listing multiple world-class cannabis companies, including TGOD, Emblem Corp. and Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF). Before joining the cannabis industry, he spent seven years working at two leading Canadian brokerage firms.
HempFusion Wellness Inc. (CBDHF), closed Friday’s trading session at $0.7651, off by 4.5891%, on 63,310 volume with 102 trades. The average volume for the last 3 months is 132,693 and the stock's 52-week low/high is $0.689999997/$3.69000005.
Recent News
- InvestorNewsBreaks - HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Issues Commendation on Proposed Hemp Access and Consumer Safety Act
- InvestorNewsBreaks - HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Releases First-Quarter 2021 Financial Report
- HempFusion Wellness Inc. (CBDHF) CEO Jason Mitchell on Q1 2021 Results - Earnings Call Transcript
Sharing Services Global Corporation (SHRG)
The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).
Sharing Services Global Corporation (OTCQB: SHRG) (the “Company”), formerly Sharing Services, Inc., has received notice from KOSSA cancelling its subsidiary license previously issued. The Company still has plans to launch in that country and is working to resolve any outstanding issues. “It is unfortunate and disappointing that days before our launch in South Korea we received this news. We have been fully compliant with all requirements during the process and were issued the licensed in February. The Company is currently working on this situation and we hope to have a positive resolution soon for all the hard-working representatives in that country,” stated John “JT” Thatch, CEO of SHRG.
Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.
Proprietary Products
SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.
The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.
Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.
Global Network of Elepreneurs
Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.
SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”
Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.
In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.
Continued Momentum as Industry Leader
These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.
SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.
These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.
These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.
Preparing for Success
SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.
Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com
Sharing Services Global Corporation (SHRG), closed Friday’s trading session at $0.22, off by 2.2222%, on 6,077 volume with 8 trades. The average volume for the last 3 months is 172,341 and the stock's 52-week low/high is $0.054999999/$0.730000019.
Recent News
- Sharing Services Global Corporation (SHRG) Receives Notice on South Korea License
- InvestorNewsBreaks - Sharing Services Global Corporation (SHRG) Announces Global Expansion of The Happy Co., 'Hapi Travel Destinations' as Name for New Travel Brand
- InvestorNewsBreaks - Sharing Services Global Corporation (SHRG) Announces Strategic Happy Co. Appointment
Healthy Extracts Inc. (HYEX)
The QualityStocks Daily Newsletter would like to spotlight Healthy Extracts Inc. (HYEX).
Healthy Extracts (OTCQB: HYEX) recently announced the addition of Dr. Joel Kahn, MD, to its medical board. Dr. Kahn, a world-renowned, triple board-certified cardiology specialist with 30 years of experience, has used BergametNA Citrus Bergamot SuperFruit(TM) on thousands of patients and approves the product’s cardiovascular health benefits. He has also personally conducted clinical studies that confirm the effectiveness of the superfruit, the main ingredient in BergametNA’s product line. HYEX CEO Duke Pitts noted that the company was delighted to welcome Dr. Kahn to its medical board. A recent article discussing this indicates that Pitts considers the addition of Dr. Kahn to the company’s already talented team of specialized doctors as instrumental in expanding doctor-to-doctor and consumer sales. To view the full article, visit: https://ibn.fm/zbORz
Healthy Extracts Inc. (HYEX) Healthy Extracts Inc. (HYEX), through its growing portfolio of wholly owned subsidiaries, is engaged in the proprietary research and development of natural plant-based formulations, sales, and distribution of cardiovascular and neuro products. The company’s focus is to advance its market positions in the broader health industry through the unique assets and operations of its science-based BergaMet North America and Ultimate Brain Nutrients (“UBN”) subsidiaries and to offer better lifestyles through superior health technology.
BergaMet North America
BergaMet NA is engaged in the sale and distribution of a full line of proprietary product formulations derived from the rare Citrus Bergamot SuperFruit™ called “bergamot.” Bergamot is native to Southern Italy and is naturally sourced and uniquely loaded with various antioxidant polyphenols. Thanks to this composition, bergamot supports and promotes overall wellness specific to cholesterol, cardiovascular and metabolic health with no known side effects.
BergaMet NA is the only Citrus Bergamot SuperFruit™ heart health supplement backed by 17 clinical studies. The BergaMet brand supplement boasts the highest quality and concentration of polyphenols and flavonoids available anywhere in the world. It is also the only bergamot supplement approved by the prestigious Accademia del Bergamotto of Italy. BergaMet NA is the only company authorized to manufacture, distribute and sell these products in the United States, Canada and Mexico.
Consumers are including the Citrus Bergamot SuperFruit™ in their everyday personal health programs. The clinically proven antioxidant provides benefits to tens of thousands of people daily.
The company’s line of products can be found at www.bergametna.com, through Amazon, other online retailers and in doctors’ offices throughout the United States.
The BergaMet Advantage
BergaMet has been studied in 17 published clinical trials which reported results of lower LDL cholesterol, higher HDL cholesterol, lower triglycerides, lower blood pressure, lower blood glucose, increased arterial function, improved liver function and is effective as a complement to statin use.
Cardiovascular disease is the number one cause of death in the U.S. and worldwide, claiming nearly 18 million lives each year accounting for 31% of all global deaths. In the U.S., statins are one of the most commonly prescribed medicines for cardiovascular disease. The Centers for Disease Control estimates that 28% of American women and men over the age of 40 take a statin to lower the amount of cholesterol in the blood.
Taking aim at this market for cardiovascular care, BergaMet NA continues to advance the awareness of its medical-grade supplements and separate its formulation from competitors.
BergaMet NA products contain 47% BPF (bergamot polyphenolic fraction), while its closest competitors have only 38%. The company’s increased dosages (600-675mg vs 500mg) and 47% BPF are clinically proven to be more effective in improving heart health and metabolic syndrome.
BergaMet Citrus Bergamot SuperFruit™ supplements:
- Support healthy immune systems with powerful antioxidants and proprietary formulations.
- Reduce cholesterol and support healthy glucose and blood pressure levels.
- Are fully organic, vegan-friendly and dairy, gluten, soy and GMO-free.
- Contain five key unique flavonoids that make up the most powerful 47% BPF (bergamot polyphenolic fraction) in the world, providing superior results compared to their competitors.
- Have been clinically shown to increase arterial elasticity while reducing arterial and muscle inflammation.
Ultimate Brain Nutrients
Healthy Extracts’ Ultimate Brain Nutrients (“UBN”) subsidiary is a science-based company that develops unique, plant-based superior health technology neuro-products that improve brain health, including memory, cognition, focus and neuro-energy.
UBN’s KETONOMICS® proprietary formulations – targeting brain activity, focus, headache and cognitive behavior — provide multiple intellectual property license opportunities for monetizing the company’s portfolio.
License opportunities include multiple beverage formats, individual products, proprietary mixtures and other food platforms.
UBN has five unique formulation patents – one issued and four pending – targeting brain activity, focus, headache and cognitive behavior.
The UBN Advantage
UBN’s all-natural, sugar-free and caffeine-free proprietary formulations are the result of 20 years of scientific research and are positioned to provide consumer neuro-products that are natural brain solutions. UBN has filed for approval to the U.S. Food and Drug Administration (FDA) to make a Qualified Health Claim for its migraine formulation, tapping into consumer demands for healthy beverages that contribute to brain health, overall well-being and performance.
Over 50 million Americans consume unhealthy energy shots and drinks each day, while the neuro/energy market generates over $10 billion per year in revenue. Within this growing market, UBN is advancing its position to meet rising consumer demand for healthy, science-based options. The company’s KETONOMICS® proprietary formulations have been proven to naturally elevate brain energy and function, including memory, cognition and focus.
UBN’s KETONOMICS® supplementation has also been studied in sports physiology, with specific regard to its potential benefits for competitive performance and endurance.
Healthy Extracts Executive Team
Kevin “Duke” Pitts, Director, President and Chief Operating Officer
- Started and built from the ground up two multi-million-dollar businesses, one of which grew into a Top 100 retailers in the U.S.
- Unique management skills led to the development of successful teams for 35 years
- Pioneered direct marketing for a Fortune 200 company, creating a 20% increase in targeted incremental sales
- Founded Einstein’s Hemp, which developed and brought to market one of the only odorless and tasteless water-soluble CBD products in the world
- Developed and implemented digital/guerrilla marketing strategies for public and private companies focused on long-term brand position and acquisition efforts
- Specialized in customer relationship management (CRM) tools for creating the best customer experiences
- Worked in publicly traded industries for 10 years, overseeing up to $20 million in annual marketing budgets
William “Bill” Bossung, Director, Chief Financial Officer
- 35 years of diverse experience in corporate finance, insurance and accounting
- 20 years of experience with IPOs focusing on audits, FINRA and SEC regulations
- Specializes in the formation of capital raising over $100 million, recently raising $12 million for Splash Beverage
- Specializes in upgrading penny stocks companies to the NYSE or Nasdaq
- Involved in 30+ companies transitioning from private to public identities
- Founded several companies, including BCF Technology Inc., which sold to Vertafore; managing partner at Bishop Equity Partners LLC; director at Splash Beverage Group; and director of finance at Chadmoore Wireless, where he licensed channels to Nextel for $162 million
Bill Croyle, Director, Private Investor and Accomplished Senior Executive
- More than 40 years of success in the IT, energy, manufacturing, telecommunications, venture capital and finance industries
- Broad expertise includes negotiating mergers and acquisitions, as well as service and delivery contracts
- Formerly was a founder, owner or executive of EnTX Group; Impact Legacy Partners; FB Oilfield Special Tools; and Western Energy Advisors
Dr. Gerald Haase, Chief Medical Officer
- Clinical professor of surgery at the University of Colorado, School of Medicine
- Actively involved in medical research and clinical trials for 35 years
- Received U-10 grant funding from the National Institutes of Health cooperative group clinical trials program, as well as U.S. Congressional funding for Cooperative Research and Development Agreements with the Department of Defense and NASA
- Was chairman of the Department of Pediatric Surgery at Children’s Hospital Colorado; consultant surgeon to the Department of the Army; vice-chairman of the Children’s Cancer Group, a cooperative research consortium of the National Cancer Institute; on the National Board of Directors of the American Cancer Society; a senior member of the Commission on Cancer of the American College of Surgeons; and a member of the editorial board of The Annals of Surgical Oncology
- Has published 180 scientific papers and is the inventor or co-inventor of 12 issued U.S. patents for micronutrient and phytonutrient therapy, with five pending patents
- Recipient of clinical research grants and contracts funded at a several million-dollar cumulative level
- Is an editorial reviewer for medical journals and a member of numerous professional societies, including the American Association for Cancer Research, International College of Surgeons, American Academy of Pediatrics, New York Academy of Sciences and American College of Physician Executives
Healthy Extracts Inc. (HYEX), closed Friday’s trading session at $0.07, off by 1.1299%, on 5,800 volume with 4 trades. The average volume for the last 3 months is 30,710 and the stock's 52-week low/high is $0.052000001/$0.100000001.
Recent News
- BioMedNewsBreaks - Healthy Extracts Inc.'s (HYEX) Specialized Team Poised to Expand Doctor-to-Doctor, Consumer Sales
- New Study Links Neurodegenerative Diseases to Gut Bacteria Changes
- BioMedNewsBreaks - Healthy Extracts Inc. (HYEX) Poised for Opportunity in Burgeoning Global Health Products Sector
The QualityStocks Numbers Report
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Collection of All Patient Data for Phase 2b Dupuytren's Disease Trial
- Amesite Inc. (NASDAQ: AMST) - Sidoti Microcap Virtual Conference
- AmpliTech Group Inc. (NASDAQ: AMPG) - AmpliTech Group Inc.'s (NASDAQ: AMPG) New Trial Order among Positives That Could Drive Financial Turnaround
- Asia Broadband Inc. (OTC: AABB) - Asia Broadband Inc. (AABB) on Course to Increase Physical Gold Holdings with Two Potential Property Acquisitions
- Aterian, Inc. (NASDAQ: ATER) - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayPre-Market Stock Movers: 10 Top Gainers10 Top LosersMore From InvestorPlace
- Augusta Gold Corp. (CSE: G) (OTCQB: AUGG) (FSE: 11B) - InvestorNewsBreaks - Augusta Gold Corp. (TSX: G) (OTCQB: AUGG) (FSE: 11B) Releases Drill Results from Montgomery-Shoshone Exploration Program
- BAND Royalty - InvestorNewsBreaks – BAND Royalty Creating Niche in Rapidly Growing NFT Market
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology Announces the Closing of a Registered Direct Offering of $5.66 Million
- Brain Scientific Inc. (OTCQB: BRSF) - Brain Scientific Inc. (BRSF) Offers Solutions for COVID-19 EEG Accessibility
- Cannabis Strategic Ventures, Inc. (NUGS) - InvestorNewsBreaks - Cannabis Strategic Ventures (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales
- Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) - InvestorNewsBreaks - Clean Power Capital Corp. (NEO: MOVE) (FWB: 2K6) (OTC: MOTNF) Provides PowerTap Hydrogen Program Update
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Patient Enrollment in Berubicin Study
- DarioHealth Corp. (NASDAQ: DRIO) - Corporate Wellness Has Become Essential for the Health of a Company's Bottom Line
- Deltec Bank & Trust Ltd. - NetworkNewsBreaks – Deltec Bank & Trust Ltd. Delves Into Intricacies Surrounding EU Recovery Fund
- DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) - InvestorNewsBreaks - DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) Partners to Provide Brands Direct Access to Customers, Real-Time Metrics
- Emaginos Inc. - InvestorNewsBreaks – Emaginos Inc. Integrating Proven Best Practices to Transform Public Education
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - InvestorNewsBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Hosts Q1 2021 Earnings Call
- ev Transportation Services Inc. - QualityStocksNewsBreaks – ev Transportation Services Inc. (‘evTS’) Enters Strategic Agreement with Leading EVSE Company
- Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) - Rare Earth Oxides Market to Register a Fivefold Increase by 2030
- Exro Technologies Inc. (TSXV: EXRO) (OTCQB: EXROF) - Exro Successfully Pilots Battery Control System in Operating Second Life Environment
- FACT Inc. (OTC: FCTI) - FACT Inc. (OTC: FCTI) Finds Niche in Ensuring Authenticity in Art, Collectibles Market
- FingerMotion Inc. (OTCQX: FNGR) - FingerMotion Inc. (FNGR) Foresees Revenues Boost as Big Data Insurtech Solution Rolls Out
- First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) Announces Incentive Stock Options
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - Foresight Announces First Quarter 2021 Financial Results
- Friendable Inc. (FDBL) - Friendable Inc.'s (FDBL) Fan Pass Platform Offers Important Alternative Revenue Streams, While Traditional Music Streaming Companies Face Criticism
- Gage Cannabis Co. (CSE: GAGE) - 420 with CNW - Congressional Bill Seeks to Protect Cannabis Consumers from Losing Federally-Assisted Housing
- Genprex Inc. (NASDAQ: GNPX) - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) to Present in Noble Capital Markets' Virtual Roadshow
- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) - InvestorNewsBreaks - Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Announces Timing of Corporate Name Change, Share Consolidation
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) - Australian Team Develops Mining Technique That Uses Magnetic Fields Rather Than Digging
- Grapefruit USA Inc. (OTCQB: GPFT) - InvestorNewsBreaks - Grapefruit USA Inc. (GPFT) Issues Update Regarding Potential Acquisition, Joint Venture with Canadian Partner
- Green Hygienics Holdings Inc. (OTCQB: GRYN) - InvestorNewsBreaks - Green Hygienics Holdings Inc. (GRYN) Enters Agreement with Leading Mexican Academic Research Institution to Advance ECS Research
- Healthtech Solutions Inc. (OTC: HLTT) - InvestorNewsBreaks - Healthtech Solutions Inc. (HLTT) Announces Strategic CEO Appointment
- Healthy Extracts Inc. (HYEX) - New Study Links Neurodegenerative Diseases to Gut Bacteria Changes
- HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) - InvestorNewsBreaks - HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Releases First-Quarter 2021 Financial Report
- Hemptown Organics Corp. - QualityStocksNewsBreaks – Hemptown Organic Corp. Announces Strategic Engagement with Leading Digital Marketing Firm, Hawke Media
- Hero Technologies Inc. (OTC: HENC) - Hero Technologies Inc. (HENC) Receives Confirmation of Value of Veteran Hemp Acquisition
- Hollywall Entertainment Inc. (OTC: HWAL) - The Real Value in Recent Market Carnage: NFT Stocks
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) - InvestorNewsBreaks - iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Planned Release of Q1 2021 Financial Results, Conference Call
- Ideanomics Inc. (NASDAQ: IDEX) - Political Decisions Influence Ideanomics Inc IDEX and Investors Should Listen
- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) - InvestorNewsBreaks - Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Announces On-Track Progress for Demonstration of i/Blue Imaging System(TM)
- Infobird Software Co. Ltd. (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Software Co. Ltd. (NASDAQ: IFBD), CESTC Partner to Accelerate Development of China's Digital Economy
- Innovative Payment Solutions Inc. (OTCQB: IPSI) - Innovative Payment Solutions, Inc. Announces Appointment of Clifford W. Henry and Madisson G. Corbett to Board of Directors
- ISW Holdings Inc. (OTC: ISWH) - InvestorNewsBreaks - ISW Holdings Inc. (ISWH) Announces Financial, Operational Highlights for Quarter-Ended March 31, 2021
- Kaival Brands Innovations Group Inc. (KAVL) - InvestorNewsBreaks - Kaival Brands Innovations Group Inc. (KAVL) Enters Strategic Partnership with Grocery Supply Warehouse
- Knightscope, Inc. - QualityStocksNewsBreaks – Knightscope Inc. Announces New Ways to Keep in Touch, Launch of Knightscope Store
- LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) - InvestorNewsBreaks - LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Announces Sales Team Expansion
- Lottery.com - InvestorNewsBreaks – Lottery.com Offers Key Features for Unique Experience
- Mobius Interactive Ltd. - Mobius Interactive Ltd. – The Profits and Benefits of a Female CEO
- Net Element (NASDAQ: NETE) - Dutch City Starts Feeding the Grid Using EVs
- Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) - InvestorNewsBreaks - - Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) (NEO: NTAR) (FSE: N29) to Host LiveX Showcase Event Featuring Guest Speaker Gary Vee
- Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) - Pac Roots Cannabis Corp.'S (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Focus on Premium Genetics, Iconic Branding Differentiates Products in Competitive Marketplace
- Perpetual Industries Inc. (OTC: PRPI) - InvestorNewsBreaks - Perpetual Industries Inc. (PRPI) Exec Featured in Most Recent Stock2Me Podcast
- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Brand Portfolio With Ultra-Premium Cold-Pressed Juice; Announces Closing of Little West LLC
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) - InvestorNewsBreaks - Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Opens Functional Mushroom Direct-to-Consumer Store on Amazon
- PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) - InvestorNewsBreaks - PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), Atlis Motor Vehicles Enter Strategic MOU
- Predictive Oncology (NASDAQ: POAI) - New Technique Promises to Deliver Cancer Drugs More Effectively
- Pressure BioSciences Inc. (PBIO) - Pressure BioSciences, Inc. Reports Resurgent Growth with Strong First Quarter 2021 Financial Results and Provides Business Update
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - Processa Pharmaceuticals Announces First Patient Dosed in its Randomized Double-Blind, Placebo-Controlled Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) - 420 with CNW - Chamber of Commerce Head Thinks 2021 Illinois Cannabis Sales Could Exceed $1B
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Is Mobilizing 30 Turn-Key Grow Pods to Provide Florida With Premium Cannabis
- RIV Capital Inc. (formerly Canopy Rivers Inc. (TSX: RIV) (CNPOF)) - RIV Capital Sets Date for Fourth Quarter and Fiscal Year 2021 Financial Results
- RYAH Group Inc. (CSE: RYAH) - 420 with CNW - CBD Firm's Appeal Could Allow Cannabis, Psychedelics Companies to Get Trademarks Before Legalization
- Sanwire Corp. (SNWR) - InvestorNewsBreaks - Sanwire Corporation (SNWR) Subsidiary Launches New Label Portal, Announces New Marketing Services
- Sharing Services Global Corporation (SHRG) - InvestorNewsBreaks - Sharing Services Global Corporation (SHRG) Announces Global Expansion of The Happy Co., 'Hapi Travel Destinations' as Name for New Travel Brand
- Sigma Labs Inc. (NASDAQ: SGLB) - InvestorNewsBreaks - Sigma Labs Inc. (NASDAQ: SGLB) Announces Release of Next-Generation PrintRite3D 7.0
- Siyata Mobile Inc. (NASDAQ: SYTA) (TSXV: SIM) - Siyata Mobile Receives Nasdaq Notice Relating to its Delayed Annual Report on Form 20-F Filing
- Sonoma Biologics Corp. - InvestorNewsBreaks – Sonoma Biologics Corp. Stands Distinct with Science-Based Approach
- Spectrum Global Solutions, Inc. (SGSI) - Spectrum Global Solutions Reports Over $4 Million in Revenue For First Quarter 2021, Narrows Operating Loss for Period
- Splash Beverage Group Inc. (OTCQB: SBEV) - InvestorNewsBreaks - Splash Beverage Group Inc. (SBEV) Partners to Expedite Growth, Exposure of Unique Portfolio
- SRAX Inc. (NASDAQ: SRAX) - InvestorNewsBreaks - SRAX (NASDAQ: SRAX) Releases Q1 Revenue Growth, Increases Full-Year Guidance
- StorEn Technologies Inc. - InvestorNewsBreaks – Why StorEn Technologies Inc. Is ‘One to Watch’
- Standard Lithium Ltd. (TSXV: SLL) (FRA: S5L) (OTCQX: STLHF) - InvestorNewsBreaks - Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Commences PEA Work on TETRA Property
- Sustainable Green Team Ltd. (SGTM) - InvestorNewsBreaks - Sustainable Green Team Ltd.'s (SGTM) Vertically Integrated Operations Founded Around Sustainability
- TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) - InvestorNewsBreaks - TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Product Packaging, Price Creates Competitive Advantages in UK Market
- The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) - InvestorNewsBreaks - The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces A88CBD Partnership with Barstool Sports
- The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) - InvestorNewsBreaks - The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Q1 2021 Financial Report, Corporate Updates
- The Movie Studio Inc. (MVES) - InvestorNewsBreaks - The Movie Studio Inc. (MVES) Announces Official Launch of OTT Streaming Platform
- Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) - Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- Trxade Group Inc. (NASDAQ: MEDS) - TRxADE Group Announces Milestone Group Purchasing Agreement with QualityCare Pharmacies
- United Medical Equipment Business Solutions Network Inc. - United Medical Equipment Business Solutions Network Inc. Provides Patient Care and Education in One Convenient App
- Uranium Energy Corp. (NYSE American: UEC) - IEA Says Rising Metals Prices Could Jeopardize Clean Energy Plans
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Presentation Schedule for June Investor Conferences
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - BioMedNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Appoints Widely Acclaimed Leader as New Medical Director of Clinical Education
- Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) - InvestorNewsBreaks - Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Joins NYSE-Listed Cannabis ETF
- Wrap Technologies Inc. (NASDAQ: WRAP) - First Agency Deploys De-escalation Platform of WRAP Reality and BolaWrap
- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) - InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Proprietary Covid-ID Lab to Launch in Germany
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Collection of All Patient Data for Phase 2b Dupuytren's Disease Trial
- Amesite Inc. (NASDAQ: AMST) - Sidoti Microcap Virtual Conference
- AmpliTech Group Inc. (NASDAQ: AMPG) - AmpliTech Group Inc.'s (NASDAQ: AMPG) New Trial Order among Positives That Could Drive Financial Turnaround
- Asia Broadband Inc. (OTC: AABB) - Asia Broadband Inc. (AABB) on Course to Increase Physical Gold Holdings with Two Potential Property Acquisitions
- Aterian, Inc. (NASDAQ: ATER) - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayPre-Market Stock Movers: 10 Top Gainers10 Top LosersMore From InvestorPlace
- Augusta Gold Corp. (CSE: G) (OTCQB: AUGG) (FSE: 11B) - InvestorNewsBreaks - Augusta Gold Corp. (TSX: G) (OTCQB: AUGG) (FSE: 11B) Releases Drill Results from Montgomery-Shoshone Exploration Program
- BAND Royalty - InvestorNewsBreaks – BAND Royalty Creating Niche in Rapidly Growing NFT Market
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology Announces the Closing of a Registered Direct Offering of $5.66 Million
- Brain Scientific Inc. (OTCQB: BRSF) - Brain Scientific Inc. (BRSF) Offers Solutions for COVID-19 EEG Accessibility
- Cannabis Strategic Ventures, Inc. (NUGS) - InvestorNewsBreaks - Cannabis Strategic Ventures (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales
- Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) - InvestorNewsBreaks - Clean Power Capital Corp. (NEO: MOVE) (FWB: 2K6) (OTC: MOTNF) Provides PowerTap Hydrogen Program Update
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Patient Enrollment in Berubicin Study
- DarioHealth Corp. (NASDAQ: DRIO) - Corporate Wellness Has Become Essential for the Health of a Company's Bottom Line
- Deltec Bank & Trust Ltd. - NetworkNewsBreaks – Deltec Bank & Trust Ltd. Delves Into Intricacies Surrounding EU Recovery Fund
- DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) - InvestorNewsBreaks - DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) Partners to Provide Brands Direct Access to Customers, Real-Time Metrics
- Emaginos Inc. - InvestorNewsBreaks – Emaginos Inc. Integrating Proven Best Practices to Transform Public Education
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - InvestorNewsBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Hosts Q1 2021 Earnings Call
- ev Transportation Services Inc. - QualityStocksNewsBreaks – ev Transportation Services Inc. (‘evTS’) Enters Strategic Agreement with Leading EVSE Company
- Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) - Rare Earth Oxides Market to Register a Fivefold Increase by 2030
- Exro Technologies Inc. (TSXV: EXRO) (OTCQB: EXROF) - Exro Successfully Pilots Battery Control System in Operating Second Life Environment
- FACT Inc. (OTC: FCTI) - FACT Inc. (OTC: FCTI) Finds Niche in Ensuring Authenticity in Art, Collectibles Market
- FingerMotion Inc. (OTCQX: FNGR) - FingerMotion Inc. (FNGR) Foresees Revenues Boost as Big Data Insurtech Solution Rolls Out
- First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) Announces Incentive Stock Options
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - Foresight Announces First Quarter 2021 Financial Results
- Friendable Inc. (FDBL) - Friendable Inc.'s (FDBL) Fan Pass Platform Offers Important Alternative Revenue Streams, While Traditional Music Streaming Companies Face Criticism
- Gage Cannabis Co. (CSE: GAGE) - 420 with CNW - Congressional Bill Seeks to Protect Cannabis Consumers from Losing Federally-Assisted Housing
- Genprex Inc. (NASDAQ: GNPX) - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) to Present in Noble Capital Markets' Virtual Roadshow
- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) - InvestorNewsBreaks - Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Announces Timing of Corporate Name Change, Share Consolidation
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) - Australian Team Develops Mining Technique That Uses Magnetic Fields Rather Than Digging
- Grapefruit USA Inc. (OTCQB: GPFT) - InvestorNewsBreaks - Grapefruit USA Inc. (GPFT) Issues Update Regarding Potential Acquisition, Joint Venture with Canadian Partner
- Green Hygienics Holdings Inc. (OTCQB: GRYN) - InvestorNewsBreaks - Green Hygienics Holdings Inc. (GRYN) Enters Agreement with Leading Mexican Academic Research Institution to Advance ECS Research
- Healthtech Solutions Inc. (OTC: HLTT) - InvestorNewsBreaks - Healthtech Solutions Inc. (HLTT) Announces Strategic CEO Appointment
- Healthy Extracts Inc. (HYEX) - New Study Links Neurodegenerative Diseases to Gut Bacteria Changes
- HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) - InvestorNewsBreaks - HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Releases First-Quarter 2021 Financial Report
- Hemptown Organics Corp. - QualityStocksNewsBreaks – Hemptown Organic Corp. Announces Strategic Engagement with Leading Digital Marketing Firm, Hawke Media
- Hero Technologies Inc. (OTC: HENC) - Hero Technologies Inc. (HENC) Receives Confirmation of Value of Veteran Hemp Acquisition
- Hollywall Entertainment Inc. (OTC: HWAL) - The Real Value in Recent Market Carnage: NFT Stocks
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) - InvestorNewsBreaks - iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Planned Release of Q1 2021 Financial Results, Conference Call
- Ideanomics Inc. (NASDAQ: IDEX) - Political Decisions Influence Ideanomics Inc IDEX and Investors Should Listen
- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) - InvestorNewsBreaks - Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Announces On-Track Progress for Demonstration of i/Blue Imaging System(TM)
- Infobird Software Co. Ltd. (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Software Co. Ltd. (NASDAQ: IFBD), CESTC Partner to Accelerate Development of China's Digital Economy
- Innovative Payment Solutions Inc. (OTCQB: IPSI) - Innovative Payment Solutions, Inc. Announces Appointment of Clifford W. Henry and Madisson G. Corbett to Board of Directors
- ISW Holdings Inc. (OTC: ISWH) - InvestorNewsBreaks - ISW Holdings Inc. (ISWH) Announces Financial, Operational Highlights for Quarter-Ended March 31, 2021
- Kaival Brands Innovations Group Inc. (KAVL) - InvestorNewsBreaks - Kaival Brands Innovations Group Inc. (KAVL) Enters Strategic Partnership with Grocery Supply Warehouse
- Knightscope, Inc. - QualityStocksNewsBreaks – Knightscope Inc. Announces New Ways to Keep in Touch, Launch of Knightscope Store
- LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) - InvestorNewsBreaks - LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Announces Sales Team Expansion
- Lottery.com - InvestorNewsBreaks – Lottery.com Offers Key Features for Unique Experience
- Mobius Interactive Ltd. - Mobius Interactive Ltd. – The Profits and Benefits of a Female CEO
- Net Element (NASDAQ: NETE) - Dutch City Starts Feeding the Grid Using EVs
- Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) - InvestorNewsBreaks - - Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) (NEO: NTAR) (FSE: N29) to Host LiveX Showcase Event Featuring Guest Speaker Gary Vee
- Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) - Pac Roots Cannabis Corp.'S (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Focus on Premium Genetics, Iconic Branding Differentiates Products in Competitive Marketplace
- Perpetual Industries Inc. (OTC: PRPI) - InvestorNewsBreaks - Perpetual Industries Inc. (PRPI) Exec Featured in Most Recent Stock2Me Podcast
- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Brand Portfolio With Ultra-Premium Cold-Pressed Juice; Announces Closing of Little West LLC
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) - InvestorNewsBreaks - Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Opens Functional Mushroom Direct-to-Consumer Store on Amazon
- PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) - InvestorNewsBreaks - PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), Atlis Motor Vehicles Enter Strategic MOU
- Predictive Oncology (NASDAQ: POAI) - New Technique Promises to Deliver Cancer Drugs More Effectively
- Pressure BioSciences Inc. (PBIO) - Pressure BioSciences, Inc. Reports Resurgent Growth with Strong First Quarter 2021 Financial Results and Provides Business Update
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - Processa Pharmaceuticals Announces First Patient Dosed in its Randomized Double-Blind, Placebo-Controlled Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) - 420 with CNW - Chamber of Commerce Head Thinks 2021 Illinois Cannabis Sales Could Exceed $1B
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Is Mobilizing 30 Turn-Key Grow Pods to Provide Florida With Premium Cannabis
- RIV Capital Inc. (formerly Canopy Rivers Inc. (TSX: RIV) (CNPOF)) - RIV Capital Sets Date for Fourth Quarter and Fiscal Year 2021 Financial Results
- RYAH Group Inc. (CSE: RYAH) - 420 with CNW - CBD Firm's Appeal Could Allow Cannabis, Psychedelics Companies to Get Trademarks Before Legalization
- Sanwire Corp. (SNWR) - InvestorNewsBreaks - Sanwire Corporation (SNWR) Subsidiary Launches New Label Portal, Announces New Marketing Services
- Sharing Services Global Corporation (SHRG) - InvestorNewsBreaks - Sharing Services Global Corporation (SHRG) Announces Global Expansion of The Happy Co., 'Hapi Travel Destinations' as Name for New Travel Brand
- Sigma Labs Inc. (NASDAQ: SGLB) - InvestorNewsBreaks - Sigma Labs Inc. (NASDAQ: SGLB) Announces Release of Next-Generation PrintRite3D 7.0
- Siyata Mobile Inc. (NASDAQ: SYTA) (TSXV: SIM) - Siyata Mobile Receives Nasdaq Notice Relating to its Delayed Annual Report on Form 20-F Filing
- Sonoma Biologics Corp. - InvestorNewsBreaks – Sonoma Biologics Corp. Stands Distinct with Science-Based Approach
- Spectrum Global Solutions, Inc. (SGSI) - Spectrum Global Solutions Reports Over $4 Million in Revenue For First Quarter 2021, Narrows Operating Loss for Period
- Splash Beverage Group Inc. (OTCQB: SBEV) - InvestorNewsBreaks - Splash Beverage Group Inc. (SBEV) Partners to Expedite Growth, Exposure of Unique Portfolio
- SRAX Inc. (NASDAQ: SRAX) - InvestorNewsBreaks - SRAX (NASDAQ: SRAX) Releases Q1 Revenue Growth, Increases Full-Year Guidance
- StorEn Technologies Inc. - InvestorNewsBreaks – Why StorEn Technologies Inc. Is ‘One to Watch’
- Standard Lithium Ltd. (TSXV: SLL) (FRA: S5L) (OTCQX: STLHF) - InvestorNewsBreaks - Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Commences PEA Work on TETRA Property
- Sustainable Green Team Ltd. (SGTM) - InvestorNewsBreaks - Sustainable Green Team Ltd.'s (SGTM) Vertically Integrated Operations Founded Around Sustainability
- TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) - InvestorNewsBreaks - TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Product Packaging, Price Creates Competitive Advantages in UK Market
- The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) - InvestorNewsBreaks - The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces A88CBD Partnership with Barstool Sports
- The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) - InvestorNewsBreaks - The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Q1 2021 Financial Report, Corporate Updates
- The Movie Studio Inc. (MVES) - InvestorNewsBreaks - The Movie Studio Inc. (MVES) Announces Official Launch of OTT Streaming Platform
- Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) - Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- Trxade Group Inc. (NASDAQ: MEDS) - TRxADE Group Announces Milestone Group Purchasing Agreement with QualityCare Pharmacies
- United Medical Equipment Business Solutions Network Inc. - United Medical Equipment Business Solutions Network Inc. Provides Patient Care and Education in One Convenient App
- Uranium Energy Corp. (NYSE American: UEC) - IEA Says Rising Metals Prices Could Jeopardize Clean Energy Plans
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Presentation Schedule for June Investor Conferences
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - BioMedNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Appoints Widely Acclaimed Leader as New Medical Director of Clinical Education
- Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) - InvestorNewsBreaks - Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Joins NYSE-Listed Cannabis ETF
- Wrap Technologies Inc. (NASDAQ: WRAP) - First Agency Deploys De-escalation Platform of WRAP Reality and BolaWrap
- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) - InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Proprietary Covid-ID Lab to Launch in Germany
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Collection of All Patient Data for Phase 2b Dupuytren's Disease Trial
- Amesite Inc. (NASDAQ: AMST) - Sidoti Microcap Virtual Conference
- AmpliTech Group Inc. (NASDAQ: AMPG) - AmpliTech Group Inc.'s (NASDAQ: AMPG) New Trial Order among Positives That Could Drive Financial Turnaround
- Asia Broadband Inc. (OTC: AABB) - Asia Broadband Inc. (AABB) on Course to Increase Physical Gold Holdings with Two Potential Property Acquisitions
- Aterian, Inc. (NASDAQ: ATER) - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayPre-Market Stock Movers: 10 Top Gainers10 Top LosersMore From InvestorPlace
- Augusta Gold Corp. (CSE: G) (OTCQB: AUGG) (FSE: 11B) - InvestorNewsBreaks - Augusta Gold Corp. (TSX: G) (OTCQB: AUGG) (FSE: 11B) Releases Drill Results from Montgomery-Shoshone Exploration Program
- BAND Royalty - InvestorNewsBreaks – BAND Royalty Creating Niche in Rapidly Growing NFT Market
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology Announces the Closing of a Registered Direct Offering of $5.66 Million
- Brain Scientific Inc. (OTCQB: BRSF) - Brain Scientific Inc. (BRSF) Offers Solutions for COVID-19 EEG Accessibility
- Cannabis Strategic Ventures, Inc. (NUGS) - InvestorNewsBreaks - Cannabis Strategic Ventures (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales
- Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) - InvestorNewsBreaks - Clean Power Capital Corp. (NEO: MOVE) (FWB: 2K6) (OTC: MOTNF) Provides PowerTap Hydrogen Program Update
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Patient Enrollment in Berubicin Study
- DarioHealth Corp. (NASDAQ: DRIO) - Corporate Wellness Has Become Essential for the Health of a Company's Bottom Line
- Deltec Bank & Trust Ltd. - NetworkNewsBreaks – Deltec Bank & Trust Ltd. Delves Into Intricacies Surrounding EU Recovery Fund
- DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) - InvestorNewsBreaks - DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) Partners to Provide Brands Direct Access to Customers, Real-Time Metrics
- Emaginos Inc. - InvestorNewsBreaks – Emaginos Inc. Integrating Proven Best Practices to Transform Public Education
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - InvestorNewsBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Hosts Q1 2021 Earnings Call
- ev Transportation Services Inc. - QualityStocksNewsBreaks – ev Transportation Services Inc. (‘evTS’) Enters Strategic Agreement with Leading EVSE Company
- Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) - Rare Earth Oxides Market to Register a Fivefold Increase by 2030
- Exro Technologies Inc. (TSXV: EXRO) (OTCQB: EXROF) - Exro Successfully Pilots Battery Control System in Operating Second Life Environment
- FACT Inc. (OTC: FCTI) - FACT Inc. (OTC: FCTI) Finds Niche in Ensuring Authenticity in Art, Collectibles Market
- FingerMotion Inc. (OTCQX: FNGR) - FingerMotion Inc. (FNGR) Foresees Revenues Boost as Big Data Insurtech Solution Rolls Out
- First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) Announces Incentive Stock Options
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - Foresight Announces First Quarter 2021 Financial Results
- Friendable Inc. (FDBL) - Friendable Inc.'s (FDBL) Fan Pass Platform Offers Important Alternative Revenue Streams, While Traditional Music Streaming Companies Face Criticism
- Gage Cannabis Co. (CSE: GAGE) - 420 with CNW - Congressional Bill Seeks to Protect Cannabis Consumers from Losing Federally-Assisted Housing
- Genprex Inc. (NASDAQ: GNPX) - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) to Present in Noble Capital Markets' Virtual Roadshow
- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) - InvestorNewsBreaks - Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Announces Timing of Corporate Name Change, Share Consolidation
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) - Australian Team Develops Mining Technique That Uses Magnetic Fields Rather Than Digging
- Grapefruit USA Inc. (OTCQB: GPFT) - InvestorNewsBreaks - Grapefruit USA Inc. (GPFT) Issues Update Regarding Potential Acquisition, Joint Venture with Canadian Partner
- Green Hygienics Holdings Inc. (OTCQB: GRYN) - InvestorNewsBreaks - Green Hygienics Holdings Inc. (GRYN) Enters Agreement with Leading Mexican Academic Research Institution to Advance ECS Research
- Healthtech Solutions Inc. (OTC: HLTT) - InvestorNewsBreaks - Healthtech Solutions Inc. (HLTT) Announces Strategic CEO Appointment
- Healthy Extracts Inc. (HYEX) - New Study Links Neurodegenerative Diseases to Gut Bacteria Changes
- HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) - InvestorNewsBreaks - HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Releases First-Quarter 2021 Financial Report
- Hemptown Organics Corp. - QualityStocksNewsBreaks – Hemptown Organic Corp. Announces Strategic Engagement with Leading Digital Marketing Firm, Hawke Media
- Hero Technologies Inc. (OTC: HENC) - Hero Technologies Inc. (HENC) Receives Confirmation of Value of Veteran Hemp Acquisition
- Hollywall Entertainment Inc. (OTC: HWAL) - The Real Value in Recent Market Carnage: NFT Stocks
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) - InvestorNewsBreaks - iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Planned Release of Q1 2021 Financial Results, Conference Call
- Ideanomics Inc. (NASDAQ: IDEX) - Political Decisions Influence Ideanomics Inc IDEX and Investors Should Listen
- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) - InvestorNewsBreaks - Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Announces On-Track Progress for Demonstration of i/Blue Imaging System(TM)
- Infobird Software Co. Ltd. (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Software Co. Ltd. (NASDAQ: IFBD), CESTC Partner to Accelerate Development of China's Digital Economy
- Innovative Payment Solutions Inc. (OTCQB: IPSI) - Innovative Payment Solutions, Inc. Announces Appointment of Clifford W. Henry and Madisson G. Corbett to Board of Directors
- ISW Holdings Inc. (OTC: ISWH) - InvestorNewsBreaks - ISW Holdings Inc. (ISWH) Announces Financial, Operational Highlights for Quarter-Ended March 31, 2021
- Kaival Brands Innovations Group Inc. (KAVL) - InvestorNewsBreaks - Kaival Brands Innovations Group Inc. (KAVL) Enters Strategic Partnership with Grocery Supply Warehouse
- Knightscope, Inc. - QualityStocksNewsBreaks – Knightscope Inc. Announces New Ways to Keep in Touch, Launch of Knightscope Store
- LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) - InvestorNewsBreaks - LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Announces Sales Team Expansion
- Lottery.com - InvestorNewsBreaks – Lottery.com Offers Key Features for Unique Experience
- Mobius Interactive Ltd. - Mobius Interactive Ltd. – The Profits and Benefits of a Female CEO
- Net Element (NASDAQ: NETE) - Dutch City Starts Feeding the Grid Using EVs
- Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) - InvestorNewsBreaks - - Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) (NEO: NTAR) (FSE: N29) to Host LiveX Showcase Event Featuring Guest Speaker Gary Vee
- Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) - Pac Roots Cannabis Corp.'S (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Focus on Premium Genetics, Iconic Branding Differentiates Products in Competitive Marketplace
- Perpetual Industries Inc. (OTC: PRPI) - InvestorNewsBreaks - Perpetual Industries Inc. (PRPI) Exec Featured in Most Recent Stock2Me Podcast
- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Brand Portfolio With Ultra-Premium Cold-Pressed Juice; Announces Closing of Little West LLC
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) - InvestorNewsBreaks - Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Opens Functional Mushroom Direct-to-Consumer Store on Amazon
- PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) - InvestorNewsBreaks - PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), Atlis Motor Vehicles Enter Strategic MOU
- Predictive Oncology (NASDAQ: POAI) - New Technique Promises to Deliver Cancer Drugs More Effectively
- Pressure BioSciences Inc. (PBIO) - Pressure BioSciences, Inc. Reports Resurgent Growth with Strong First Quarter 2021 Financial Results and Provides Business Update
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - Processa Pharmaceuticals Announces First Patient Dosed in its Randomized Double-Blind, Placebo-Controlled Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) - 420 with CNW - Chamber of Commerce Head Thinks 2021 Illinois Cannabis Sales Could Exceed $1B
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Is Mobilizing 30 Turn-Key Grow Pods to Provide Florida With Premium Cannabis
- RIV Capital Inc. (formerly Canopy Rivers Inc. (TSX: RIV) (CNPOF)) - RIV Capital Sets Date for Fourth Quarter and Fiscal Year 2021 Financial Results
- RYAH Group Inc. (CSE: RYAH) - 420 with CNW - CBD Firm's Appeal Could Allow Cannabis, Psychedelics Companies to Get Trademarks Before Legalization
- Sanwire Corp. (SNWR) - InvestorNewsBreaks - Sanwire Corporation (SNWR) Subsidiary Launches New Label Portal, Announces New Marketing Services
- Sharing Services Global Corporation (SHRG) - InvestorNewsBreaks - Sharing Services Global Corporation (SHRG) Announces Global Expansion of The Happy Co., 'Hapi Travel Destinations' as Name for New Travel Brand
- Sigma Labs Inc. (NASDAQ: SGLB) - InvestorNewsBreaks - Sigma Labs Inc. (NASDAQ: SGLB) Announces Release of Next-Generation PrintRite3D 7.0
- Siyata Mobile Inc. (NASDAQ: SYTA) (TSXV: SIM) - Siyata Mobile Receives Nasdaq Notice Relating to its Delayed Annual Report on Form 20-F Filing
- Sonoma Biologics Corp. - InvestorNewsBreaks – Sonoma Biologics Corp. Stands Distinct with Science-Based Approach
- Spectrum Global Solutions, Inc. (SGSI) - Spectrum Global Solutions Reports Over $4 Million in Revenue For First Quarter 2021, Narrows Operating Loss for Period
- Splash Beverage Group Inc. (OTCQB: SBEV) - InvestorNewsBreaks - Splash Beverage Group Inc. (SBEV) Partners to Expedite Growth, Exposure of Unique Portfolio
- SRAX Inc. (NASDAQ: SRAX) - InvestorNewsBreaks - SRAX (NASDAQ: SRAX) Releases Q1 Revenue Growth, Increases Full-Year Guidance
- StorEn Technologies Inc. - InvestorNewsBreaks – Why StorEn Technologies Inc. Is ‘One to Watch’
- Standard Lithium Ltd. (TSXV: SLL) (FRA: S5L) (OTCQX: STLHF) - InvestorNewsBreaks - Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Commences PEA Work on TETRA Property
- Sustainable Green Team Ltd. (SGTM) - InvestorNewsBreaks - Sustainable Green Team Ltd.'s (SGTM) Vertically Integrated Operations Founded Around Sustainability
- TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) - InvestorNewsBreaks - TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Product Packaging, Price Creates Competitive Advantages in UK Market
- The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) - InvestorNewsBreaks - The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces A88CBD Partnership with Barstool Sports
- The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) - InvestorNewsBreaks - The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Q1 2021 Financial Report, Corporate Updates
- The Movie Studio Inc. (MVES) - InvestorNewsBreaks - The Movie Studio Inc. (MVES) Announces Official Launch of OTT Streaming Platform
- Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) - Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- Trxade Group Inc. (NASDAQ: MEDS) - TRxADE Group Announces Milestone Group Purchasing Agreement with QualityCare Pharmacies
- United Medical Equipment Business Solutions Network Inc. - United Medical Equipment Business Solutions Network Inc. Provides Patient Care and Education in One Convenient App
- Uranium Energy Corp. (NYSE American: UEC) - IEA Says Rising Metals Prices Could Jeopardize Clean Energy Plans
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Presentation Schedule for June Investor Conferences
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - BioMedNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Appoints Widely Acclaimed Leader as New Medical Director of Clinical Education
- Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) - InvestorNewsBreaks - Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Joins NYSE-Listed Cannabis ETF
- Wrap Technologies Inc. (NASDAQ: WRAP) - First Agency Deploys De-escalation Platform of WRAP Reality and BolaWrap
- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) - InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Proprietary Covid-ID Lab to Launch in Germany
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.